---
layout: cv
title: Russell Lewis's CV
---
# Russell Edward Lewis
Associate Professor, Infectious Diseases (MED/17)

I am a clinical pharmacist and an Associate Professor of Infectious Diseases in the Department of Medical and Surgical Sciences as the University of Bologna. I have over 20 years experience in laboratory and clinical research of antimicrobial pharmacokinetics and pharmacodynamics in immunocompromised hosts. My current research focuses on the development of prognostic risk models and decision support tools for the diagnosis and treatment of fungal infections and multidrug resistant bacteria.

<div id="webaddress"><a href="https://www.unibo.it/sitoweb/russeledward.lewis">Faculty website</a>
</div> <a href="https://russlewisid.com/">Personal website</a>
</div> 

<br>
<br>
last update: 2/02/2022


## Contact information

(Office):UO Malattie Infettive, Pad.6 <br>
IRCCS- Policlinico S. Orsola-Malpighi <br>
Alma Mater Studiorum Università di Bologna Via Massarenti, 9 <br>
Bologna, Italy 40138 <br>
Office: +39 051 214 3987 <br>
russeledward.lewis@unibo.it


(Home): Via San Giuliano, 12 <br>
Bologna, Italy 40125 <br>
+39 345 309 9843 <br>
russ.e.lewis@gmail.com

## Birthdate

03-June-1972, Salina Kansas, United States of America

## Citizenship
United States of America; Permanent Residency Visa, Italy

## Online Research Profiles
- ORCID ID: <a href="https://orcid.org/0000-0002-2002-4339">0000-0002-2002-4339</a>
- Google scholar: <a href="https://scholar.google.com/citations?hl=en&pli=1&user=5mYwM2gAAAAJ">Profile</a>
- SCOPUS: <a href="https://www.scopus.com/authid/detail.uri?authorId=7404846664">7404846664</a>

 
## Professional Experience

`2013-Present`
__Associate Professor of Infectious Diseases (MED/17) with Tenure | Dipartimento di Scienze Mediche e Chirurgiche, Alma Mater Studiorum Università di Bologna__ | Bologna, Italy

`2011-2012`
__Full Professor with Tenure, University of Houston College of Pharmacy, Department of Clinical and Administrative Sciences__ | Houston, Texas

`2005-2011`
__Associate Professor with Tenure, University of Houston College of Pharmacy, Department of Clinical and Administrative Sciences__ | Houston, Texas

`2005-2007`
__Chair, ad interm, University of Houston College of Pharmacy, Department of Clinical and Administrative Sciences__ | Houston, Texas

`2000-2011`
__Adjunct Faculty, Division of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center__ |  Houston, Texas

`1999-2005`
__Assitant Professor, University of Houston College of Pharmacy, Department of Clinical and Administrative Sciences__ | Houston, Texas

## Education 

`1990-1996`
__Doctor of Clinical Pharmacy (Pharm.D.), University of Kansas__ | Lawrence, Kansas

`1996-1997`
__Clinical Pharmacy Residency, Barnes-Jewish Hospital, Washington Univeristy Medical Center__ | St. Louis, Missouri

`1997-1999`
__Infectious Diseases Research Fellowship, University of Iowa Colleges of Pharmacy and Medicine__ | Iowa City, Iowa

## Training courses

`2005`
__Woods Hole Marine Biology Laboratories: Molecular Mycology: Current Approaches to Fungal Pathogenesis__ | Woods Hole, Massachusetts

## Professional Licensure

- __Licensed Pharmacist__: Missouri (Previously Texas)
- __Board Certified Pharmacotherapy Specialist with Added Qualifications in Infectious Diseases__: 2001-2015

## Clinical Practice Experience

`2012-Present`
__Clincial Pharmacologist, UO Malattie Infettive (Viale)-IRCCS Policlinico S. Orsola-Malpighi__ | Bologna, Italy

`2000-2011`
__Clinical Staff (Pharmacy) and Faculty (Medicine) Infectious Diseases Consultation Services, The University of Texas M.D. Anderson Cancer Center__ | Houston, Texas

`1997-1999`
__Clinical Adjunct Faculty Infectious Diseases/Internal Medicine, University of Iowa College of Pharmacy__ | Iowa City, Iowa

`1996-1997`
__Clinical Pharmacist, Barnes-Jewish Hospital__ | St. Louis, Missouri

`1995-1996`
__Pharmacy Intern, St. Francis regional Hospital__ | Topeka, Kansas

`1992-1995`
__Laboratory Research Assistant, Department of Pharmacology and Toxicology (PI: Morris Faiman, Ph.D.), University of Kansas School of Pharmacy__ | Lawrence, Kansas

## Doctoral/Post-Doctoral Students Supervised

`2002-2004`
__Nathan Widerhold, Pharm.D.__ Thesis: "Pharmacodynamics of caspofungin in a murine model of invasive aspergillosis" | Houston, Texas 

`2014-2015`
__Irene Zaghi, M.D.__  Thesis: “Diagnostic Meta-Analysis of Serum Bactericidal Testing” | Bologna, Italy 

`2018-2019`
__Giulia De Luca, M.D__ Thesis: "Use of State Transition Models to Explore the Utility of Selective Digestive Tract Decontamination in Patients Colonized with Carbapenem-Resistant Enterobacteriaceae”

`2019-2020`
__Mayleko Mohamedwais, M.D.__ Thesis: "Development and internal validation of a model to predict early invasive mold disease risk in patients undergoing allogeneic hematopoietic stem cell transplantation" | Bologna, Italy

`2018-2021`
__Irene Zaghi, M.D.__ Infectious Diseases Specialization Thesis: "Bayesian Diagnostic Meta-Analysis of Blood Time To positivity for Predicint Infection Outcome and Catheter-Related Bloodstream Infections" | Bologna, Italy

## Teaching Experience

`2021-present`
__9730- Global Health, Antimicrobial Therapy and Vaccines__ | University of Bologna, Italy
<br> Course website: <a href="https://www.uniboglobalhealth.com/">www.uniboglobalhealth.com</a> 

`2014-2021`
__79947 – Malattive Infettive II__ | University of Bologna, Italy <br>
- “Antimicrobial pharmacokinetics and pharmacodynamics” 
- “Antifungal pharmacokinetics and pharmacodynamics”

`2014-2021`
__PHAR 5208 Infectious Diseases Therapeutics, Course coordinator__ | University of Houston College of Pharmacy, Houston, Texas <br>

- “The clinician and the microbiology laboratory”
- “Aerosolized and percutaneous antibiotic dosing” 
- “Immunology of ID”
- “Antibiotic hypersensitivity and allergy” 
- “Vaccination”
- “Antifungal therapy”

`2007-2011`
__PHAR 4308. Cellular Life Sciences II__ | University of Houston College of Pharmacy, Houston, Texas <br>
- “Adversarial pathogen strategies during infection, Parts 1-3” 
- “Immunobiologicals used in transplant and oncology”

`2007-2011`
__PCOL 6371-Advanced Pharmacology II__ | University of Houston College of Pharmacy, Houston, Texas <br>
- “Principles of Host Immunity” 
- “Immunopharmacology”
- “Pharmacology of anti-inflammatory agents”

`2000-2010`
__PHCA 5209 Infectious Diseases Pharmacotherapeutics II__ | University of Houston College of Pharmacy, Houston, Texas <br>
- “Essentials of in vitro testing of antimicrobials” 
- “Molecular mechanisms of antibacterial resistance” 
-  “Quinolone antibiotics” 
-  “Macrolides, lincosamides, streptogramins, and linezolid” 
-  “Systemic antifungal agents”
-  "Immunology of Infectious Diseases” 
-  “Vaccinations” 

`2007-2010`
__University of Houston Residency Certificate Program__ | University of Houston College of Pharmacy, Houston, Texas <br>
- "Academic careers”
- "Scientific publication”

`1999-2011`
__PHAR 5581. Advanced Pharmacotherapeutics, Co-course coordinator 2004-2006)__ | University of Houston College of Pharmacy, Houston, Texas <br>
- “Systemic Fungal Infections” 
- “Infective Endocarditis”
- “Sexually Transmitted Diseases”
- “Septic Meningitis” 
- “Tuberculosis” 
- “Immunology of auto-immune diseases” 
- “Drug Hypersensitivity” 

`2001-2011`
__PHAR 5229 Research Methodologies in Pharmaceutical Research__ | University of Houston College of Pharmacy, Houston, Texas <br>
- “Animal Models in Pharmaceutical Development” 

`2001-2011`
__PHAR 5682 Infectious Diseases Clinical Clerkship__ | University of Houston College of Pharmacy, Houston, Texas <br>
- Hematological Malignancies /Hematopoetic Stem Cell Transplant Consult Service, The University of Texas M.D. Anderson Cancer Center
- Solid Tumor Malignancies Consult Service, The University of Texas M.D. Anderson Cancer Center
- Intensive Care Unit Consult Service, The University of Texas M.D. Anderson Cancer Center

`2002-2003`
__PHAR 5372 –Pharmacy Law and Ethics, Course Coordinator__ | University of Houston College of Pharmacy, Houston, Texas <br>

`2001-2005`
__PHPR 646 – Pharmacotherapy I. Invited lecturer__ | University of Kansas School of Pharmacy, Kansas Medical Center, Kansas City, Kansas <br>
- “Invasive fungal infection”
- “Sepsis” 

`2001-2011`
__Infectious Diseases Fellows Core Curriculum__ | The University of Texas M.D. Anderson Cancer Center, Houston, Texas
- “Antibiotic and Tumor-Related Fever”
- “New Treatment Modalities for Acute and Chronic Leukemia” 
- “Infectious Complications in Chronic Lymphocytic Leukemia” 
- “The Pharmacology of Sepsis”
- “Iatrogenic Immunosuppression” 
- “Overview of Antifungal Pharmacology”
- “Overview of Immunosuppression Associated with Cancer Chemotherapy” 
- “Antibiotic Hypersensitivity”

`2000-2001`
__Diabetes TX-Pharm__ | University of Houston College of Pharmacy, Houston, Texas Houston, Texas
- “Infections in the Diabetic Patient"

`2000-2011`
__PHAR 5365 Pharm.D Seminar.__ | University of Houston College of Pharmacy, Houston, Texas

`1998-1999`
__Pharmacotherapy IV__ | University of Iowa College of Pharmacy, Iowa City, Iowa 
- "Febrile neutropenia"
- "Infective endocarditis"

`1997-1999`
__Pharmacotherapy IV, Group case discussion leader__ | University of Iowa College of Pharmacy, Iowa City, Iowa 

`1997-1999`
__Introduction to Pharmaceutical Care, Group leader__ | University of Iowa College of Pharmacy, Iowa City, Iowa 

`1997-1999`
__Instructor, Infectious Diseases Research Elective__ | University of Iowa College of Pharmacy, Iowa City, Iowa 

`1997-1999`
__Instructor and context evaluator, Honors Seminar__ | University of Iowa College of Pharmacy, Iowa City, Iowa 

`1996-1997`
__Adjunct Clinical Instructor at Barnes-Jewish Hospital__ | Saint Louis College of Pharmacy, St. Louis, Missouri
- Infectious Diseases Clerkship 
- Internal Medicine Clerkship
- Critical Care Clerkship
- Ambulatory Care Clerkship (VA Medical Center)

`1996-1997`
__Infectious Diseases Pharmacotherapy__ | Saint Louis College of Pharmacy, St. Louis, Missouri
- “Overview of Microbiological Testing” 
- “Overview of Antibacterial Resistance”

## Invited Lectures
`2022`<br>

`2021`<br>	
- __Antimicrobial PK in critically-ill: CRRT, ECMO and Drug interactions__
<br> European Hematology (Virtual). Association Annual Meeting. June 11, 2021.

`2020` <br>		
- __COVID-19 and invasive aspergillosis: Lessons learned.__ 
<br> Gilead Care Webinar Series (Virtual). 
- __The growing impact of targeted chemotherapy on the treatment of invasive fungal diseases__ 
<br> Ambisome 30 year Anniversary Symposium. (Virtual). 
- __Optimizing antifungal dosing for bloodstream and intraabdominal candidiasis__
<br> Gilead CARE Meeting, Brazil (Virtual)
- __Difficult cases in managing antifungal drug interactions with targeted chemotherapies__
<br> Gilead CARE Meeting, Brazil (Virtual)
- __Managing drug interactions in the era of targeted therapies for hematological malignancies__
<br> Kings College London Hematology Grand Rounds (Virtual)

`2019`<br>

- __How I manage drug interactions in the era of targeted therapies for hematological malignancies__ 
<br>12th Annual Gilead Care Meeting, Paris, France	
- __Pharmacological basis for treatment of mucormycosis__
<br>2nd Henry Schuler Symposium on Mucormycosis, Chicago, IL USA
- __Triazole Interactions with FLT3 inhibitors__
<br> 9th Trends in Medical Mycology Nice, France
- __Echinocandin dosing, can we do better?__
<br> 9th Trends in Medical Mycology Nice, France
- __How will targeted therapies in hematological disease change the management of fungal infections?__ 
<br> 55th Annual British Society Medical Mycology Meeting, Sheffield, UK

`2018`<br>	
- __How to manage antimicrobial pharmacokinetic variability in the critically-ill patient__
<br> The European Society of Intensive Care Medicine (ESICM) Infections in ICU: Modern Management Fellowship Program: Modena, Italy
- __PK/PD issues in septic shock__
<br> Antimicrobial Therapy in Immunocompromised and Critically Ill Patients: Management and Perspectives (ATCIP), Lugano, Switzerland	
- __Debate-Are polyenes still relevant in 2018?__
<br> 20° Immunocompromised Host Society Meeting, Athens, Greece
- __Optimizing antimicrobial pharmacokinetics in the ICU patient__
<br> 20° Immunocompromised Host Society Meeting, Athens, Greece	
- __Pro-Con Debate “Con: Antifungal MICs are not as useful as you think with Cornelia Lass-Florl__
<br> 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Madrid, Spain	          
- __Principles of antifungal therapy, Principles of antibiotic therapy__
<br> Hematology resident Seminar.L'Istituto di Ematologia “Seràgnoli” Alma Mater Studiorum Università di Bologna. Bologna. Italy
- __The role of CT pulmonary angiography for the diagnosis of invasive mold disease__ 
<br> 54th Annual British Society Medical Mycology Meeting, Bristol, UK
- __Can we improve the management of invasive mold disease using CT pulmonary angiography?__ 
<br> Infectious Diseases Grand Rounds, Centre hospitalier universitaire Vaudois (CHUV),Lausanne, Switzerland,
- __The Antifungal Pipeline__ 
<br> La micologia del III millennio – 2° edizione. Pescara, Italy

`2017` <br>
- __How to manage antimicrobial pharmacokinetic variability in the critically-ill patient__ 
<br> The European Society of Intensive Care Medicine (ESICM) Infections in ICU: Modern Management Fellowship Program. Modena, Italy
- __Immunopharmacology of antifungal therapy__ 
<br> Gilead Immunology Forum, Frankfurt, Germany
- __Clinical considerations for the selection of antifungal therapy__ 
<br> Breaking the Mould Meeting. London, UK
- __Radiological diagnostics in neutropenic and non-neutropenic patients__
<br> Joint annual Meeting of the Swiss Societies for Microbiology, Infectious Diseases, Hospital Hygiene, Tropical Medicine and Parasitology, and Tropical and Travel Medicine (SSI, SSHH, SSTMP, SSTTM). Basel, Switzerland.
- __Antifungals and Kidney Injury__ 
<br> 9° Congresso Nazionale DiTMO 2017. Geneva, Italy
- __New Therapeutics for Mucormycosis__ 
<br> 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Vienna, Austria
- __Differentiating fungal versus non-fungal pathology by CT imaging__
<br> Fungal Infection Update Meeting. London, UK

`2016`<br>

- __Antifungal pharmacology in the CNS__ 
<br> Gilead CARE Meeting, Munich, Germany
- __Antifungal therapy update__ 
<br> S.Orsola-Malpighi Open Days Symposium, Bologna, Italy
- __Farmacocinetica degli immunosopressor__
<br> Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO) Cagliari, Italy
- __Farmacocinetica degli antifungin__ 
<br> Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO) Cagliari, Italy
- __Pharmacokinetics and pharmacodyanamics of antifungals__ 
<br> New Perspectives in the Treatment of Invasive Fungal Infections Meeting, Bologna, Italy
- __How to optimize liposomal amphotericin B dosing__
<br> Breaking the Mould Meeting, London, UK
- __Controversies in antifungal therapy__
<br> Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO), Bologna, Italy 
- __Targeting fungal infections in the CNS-A summary of in vitro and in vivo experience__
<br> INFORM Meeting, Dubai, UAE
- __Update on antifungal therapeutics__ 
<br> Mycology Update 2016, Parma, Italy
- __Beyond direct antifungal activity-The immunomodulatory effect of echinocandin antifungals__
<br> 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Amsterdam, Netherlands
- __Antifungal therapeutic drug monitoring-Pro/Con debate: “PRO: When we should recommend TDM.__ 
<br> European Bone Marrow Transplantation (EBMT) Annual Meeting, Valencia, Spain
- __Significant papers in infectious diseases__
<br> Update on the American Society of Hematology Meeting (Post-ASH). Genova, Italy
- __Antifungal stewardship performance indicators and assessment__
<br> Transdisciplinary ECMM Antifungal Stewardship Workshop, Wesel, Germany

`2015`<br>

- __Antifungal stewardship in hematology units__ 
<br> Italy & Spain Friendship and opinions about antimicrobial stewardship programs. Bologna, Italy
- __Reevaluating the role of liposomal amphotericin B in the treatment of life-threatening fungal diseases__
<br> Breaking the Mould Symposium” London, UK
- __Optimizing antifungal dosing__ 
<br> Ankara Infectious Diseases Symposium, Ankara, Turkey
- __Optimizing Antifungal Dosing__
<br> Turkish Society of Haematology, Istanbul, Turkey
- __Do we routinely underdose antifungal therapy?__
<br> Izmir Infectious Diseases Symposium, Izmir, Turkey
- __Antimicrobial Susceptibility Testing-A view from the pharmacologist__
<br> XI Corso Avanzato Di Terapia Antibiotica Pisa, Italy

`2014`<br>

- __Safety and toxicity of antifungal therapy__
<br> Infezioni fungine nel trapianto di organo solido: un anno dopo. Bologna, 
- __Risk Models for Invasive Fungal Disease__ 
<br> 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, USA
- __Optimizing antimicrobial therapy in the critically-ill-__
<br> Sepsi: Certezze Controversie nella diagnosi e nella gestion, Forli, Italy
- __Antimicrobial Pharmacokinetics and Dynamics in the Critically-Ill__
<br> Stage Formativo. Società Italiana di Malattie Infettive e Tropicali (SIMIT). Bologna, Italy
- __Antifungal penetration into difficult sites__
<br> 18th Biennial Symposium of the Immunocompromised Host Society (ICHS), Berlin, Germany
- __Management of MDR organisms__
<br> 18th Biennial Symposium of the Immunocompromised Host Society (ICHS), Berlin, Germany
- __Risk-Assessment for Invasive Mold Diseases__
<br> 18th Biennial Symposium of the Immunocompromised Host Society (ICHS), Berlin, Germany
- __Key strategies for managing breakthrough fungal infections__
<br> Paul Ehrlich Society for Chemotherapy-Spring Mycoses Meetings, Bonn, Germany
- __Filling the Gaps-New tools to identify invasive mold disease in hematology patients__
<br> Visiting Professor Grand Rounds, Infectious Diseases, University of Cologne, Cologne Germany
- __Drug interactions and tolerability of triazoles__ 
<br> 6th Advances Against Aspergillus Conference, Madrid, Spain

`2013`<br>

- __Antimicrobial Susceptibility Testing-A view from the pharmacologist__
<br> X Corso Avanzato Di Terapia Antibiotica, Pisa, Italy
- __PK:PD For the clinician-A 4 part lecture series__
<br> Invited Professor, Infectious Diseases Unit, University of Modena Modena, Italy
- __Interazioni farmacologiche fra antifungini e farmaci antirigett__
<br> Infezioni fungine nel trapianto di organo solido: esperienze a confronto, Bologna, Italy
- __PK:PD driven choice of antimicrobials in abdominal sepsis__
<br> Il Rischio infettivo in chirurgia addominale, Bologna, Italy
- __Combination antifungal therapy-bench to bedside__
<br> 7th International Transplant Infectious Diseases Conference, Vienna, Austria
- __Clinical Case- Voriconazole associated photoxicity__
7th International Transplant Infectious Diseases Conference, Vienna, Austria
- __Antimicrobial Pharmacokinetics and Dynamics in the Critically-Ill__
<br> Stage Formativo. Società Italiana di Malattie Infettive e Tropicali (SIMIT). Bologna, Italy
- __Risk model for invasive mold disease in hematology patient__
<br> Fungal Diseases in Hematology: Translating Basic Science into Clinical Practice. Parma, Italy
- __Fungal Meningitis Outbreak in the United States__
<br> 7° Congresso Nazionale DiTMO - Diagnostica E Terapia Delle Micosi Oppotuniche” Genoa, Italy
- __Antimicrobial Pharmacokinetics and Dynamics in the Critically-Ill__
<br> Stage Formativo. Società Italiana di Malettie Infettive e Tropicali (SIMIT).  Bologna, Italy
- __Overview of animal models of mucormycosis__ 
<br> ISHAM Zygomyctes workshop April, 2013, Utrecht, Netherlands

`2012`<br>
2012	“Optimizing antifungal therapy through pharmacokinetic/pharmacodynamics principles”. Infectious Diseases Society of Portugal, Lisbon, October 2012.

2012	“Using Pharmacodynamics to set antifungal susceptibility breakpoints” 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September, 2012.

2012	“Treatment of MDR P. aeruginosa and A. baumanii Infections.” 17th International Symposium on Infections in Immunocompromised Hosts. Genoa, Italy

2012	“Dose Escalation Strategies of Liposomal Amphotericin B In the Treatment of Experimental Aspergillus terreus Pneumonia.” 18th Congress on the International Society for Human and Animal Mycology, Berlin, Germany

2011	“Antimicrobial Pharmacokinetics and Dynamics in the Critically-Ill” Stage Formativo. Società Italiana di Malettie Infettive e Tropicali (SIMIT). December 2012, Bologna, Italy

2011	“Is Antifungal Susceptibility Testing Necessary in the Management of Invasive Candidiasis?” Pro-Con Debate. 49th Infectious Diseases Society of America Annual Meeting, Boston, MA
2011	“Overview of Antifungal Pharmacology” Sabati Ematologici della Romagna. Meldola, Italy 2011	“Overview of the Immunopharmacological Mechanisms of Antifungals” Aggionarmenti in
Terapia Antifungina: La Parola Agli Esperti, Bologna, Italy

2010	“Optimized antifungal prophylaxis in the high-risk patient” CE program given at the 45th Annual Midyear Meeting of the American Society for Health System Pharmacy, Anaheim, California

2010	“Managing drug interactions with immunosuppressant agents” Infectious Diseases Society of America (IDSA) 48th Annual Meeting, Vancouver, CA

2010	“Challenging Cases in Antifungal Therapeutic Drug Monitoring” Infectious Diseases Society of America (IDSA) 48th Annual Meeting, Vancouver, CA

2010	“The interplay of innate immunity and antifungal resistance” Astellas Pharmaceutical Global Advisory, Vancouver, CA

2010	“Triazole antifungal pharmacokinetics and pharmacodynamics” CE program delivered with John Perfect (Duke University), Peter Pappas (University of Alabama-Birmingham), Libby-Dodds Ashley (University of Rochester), Boston, MA

2010	“Update on the Management of Invasive Fungal Infections” University of Illinois-Chicago Infectious Diseases CME Symposium, Chicago, IL

2010	“The Ins and Outs of Scientific Publication” Harris County Hospital Resident and Faculty Development Series, Houston, TX

2010	“Aspergillus, steroids and antifungals- What every patient should know.” 3rd Advances Against Aspergillus Meeting, Rome, Italy

2010	“Antibiotic Resistance Concerns in the Gyn-Onc Patient” Gynecology-Oncology Grand Rounds. The University of Texas M.D. Anderson Cancer Center, Houston, TX

2010	“How does antifungal pharmacology differ for Mucormycosis vs. Aspergillosis?” Henry Schuler Memorial Symposium. Chicago, IL

2009	“Managing antifungal nephrotoxicity and hepatotoxicity” 47th Meeting of the Infectious Diseases Society of America, Philadelphia, PA

2009	“Managing cytomegalovirus infections in transplant patients” –Hematology Oncology Pharmacist Association (HOPA) CME webinar with Allison Gulbis, Pharm.D. (M.D. Anderson Cancer Center), Houston, Texas

2009	“Getting with the Guidelines- Management of Invasive Candidiasis.” CME Lecture Series with Enduring Materials. Onsite lectures provided in Philadelphia, PA; Denver CO, San Jose, CA and Los Angeles, CA.

2009	“Controversies and questions surrounding the antifungal formulary” Teleconference CME series.
Broadlane Pharmacy Management Group., Houston, Texas

2009	“Where are the new antibiotics?” University of Houston College of Pharmacy Infectious Diseases Pharmacy CE Symposium, Houston, TX

2009	“Pharmacokinetic-pharmacodynamic optimization of antimicrobial dosing in the neutropenic patient.”
“ New antimicrobials for neutropenic fever.”
17th Annual King Hussein Cancer Center Conference, Amman, Jordan

2009	“Controversies in the Management of Invasive Candidiasis” Society of Hospital Medicine 2009 Annual Meeting, Chicago, IL

2009	“Key Pharmacological Concerns in the Management of Invasive Fungal Infections.” Visiting Professor- Case Discussions of Difficult Cases of Invasive Fungal Infections” Peking Medical University / College of Pharmacy, Beijing, China

2009	“Intrapulmonary drug delivery and interactions with host cells” 4th Trends In Medical Mycology (TIMM) Annual Meeting, Athens, Greece

2009	“New Antimicrobials and Antibiotic Dosing Strategies in Neutropenic Fever” Hematologic Malignancies Conference 2009. Brussels, Belgium

2009	“Controversies in the Management of Invasive Candidiasis” 5th Annual Infectious Diseases- Critical Care Pharmacy CE Conference, Toronto, ON, Canada

2008	“Improving the pharmacology of invasive mould infections” Infectious Diseases Grand Rounds, Memorial Sloan-Kettering Cancer Center, New York, NY

2008	“Evidence versus pragmatism in managing invasive candidiasis” Infectious Diseases Grand Rounds, University of Nebraska Medical Center, Omaha, NE

2008	“Cases in antifungal therapeutic drug monitoring.” Houston Infectious Diseases Pharmacy 
	Network. Houston, Texas

2007	“A case for fluconazole as front-line therapy in invasive candidiasis: Pro-con debate” American Society of Heath-System Pharmacy Annual Meeting, Las Vegas, NV
2007	“Systemic Antifungal Therapy-What every clinician should know.” American Society of Heath-System Pharmacy Annual Meeting, Las Vegas, NV
2007	“Interpreting Antifungal Susceptibility Testing. “Pre-Symposium Workshop. 47th Interescience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL
2007	“Salvage Antifungal Therapy, Combination Therapy, and Antifungal Pharmacodynamics.” AB Biodisk ABLE Course, Stockholm Sweden
2007	“Antifungal Therapeutic Drug Monitoring.” Pharmacy Grand Rounds, Memorial Sloan-Kettering Cancer Center, New York, NY
2007	“What are the real differences between the echinocandins?” Department of Hematology and Transplantation. Oregon Health Sciences Center, Portland, OR
2007	“Managing infections in the immunocompromised host.” Hematology Oncology Pharmacist Association (HOPA) Annual Meeting. Denver, CO
2007	“Antifungal formulary.” City of Hope Pharmacotherapy Symposium. Anaheim, CA
2007	“Antifungal pharmacodynamics- A focus on the echinocandins.” 17th European Conference on Chemotherapy, Microbiology and Infectious Diseases. Munich, Germany
2007	“Antifungal Therapeutic Drug Monitoring.” Blood and Marrow Transplantation Case Conference. M.D. Anderson Cancer Center, Houston, TX.
2006	“Making sense of the antifungal formulary. “Malaysian Society of Hematology Conference, Kuala Lumpur, Malaysia.
2006	“Role of new antifungal agents in the management of invasive fungal infections.” Hematology Grand Rounds. Hong Kong Sanatorium Hospital. Hong Kong, China
2006	“New drugs and new opportunities for combination antifungal therapy. “Grand Rounds. Queen Mary Hospital. Hong Kong, China
2006	“Role of new antifungal agents in the management of invasive fungal infections.” City Hematology Conference. Beijing China and Shanghai, China
2006	“Antifungal Therapy-Consensus and Controversy.” UCSF Medical Center Pharmacy Forum. San Francisco, CA
2006	“Invasive fungal infection-consensus and controversies” UCLA Infectious Diseases Grand Rounds, Los Angeles, CA
2006	“Management of invasive fungal infections-the MDACC approach” ABLE Susceptibility Course, Stockholm, Sweden
2006	“Antifungal Formulary 2006” Tennessee ACCP Summer Chapter Meeting. Memphis, TN
2006	“Antifungal Formulary 2006” St. Jude’s Children’s Hospital, Memphis, TN
2006	“Antifungal Controversies 2006” Vanderbilt Department of Infectious Diseases, Nashville, TN

2006	“Conundrums of testing antifungal combinations in the laboratory” “Difficulties in establishing in vitro/in vivo correlations with antifungal activity.” International Society of Human and Animal Mycology Congress, Paris, France

2006	“Antifungal formulary 2006” Organ Health Sciences Center. Department of Infectious Diseases, Portland, OR

2006	“Antifungal formulary-Best picks” University of Houston College of Pharmacy Infectious Diseases CE Symposium, Houston, TX

2006	“Do we routinely underdose antifungal therapy?” British Society for Medical Mycology Annual Meeting, Clontarf Castle, Dublin, Ireland

2005	“Managing Drug Interactions in the Patient with Aspergillosis” 2nd Annual Advances Against Aspergillosis Meeting, Athens Greece

2006	“Overview of Antifungal Pharmacology” Frontline CE Symposium. Houston, TX

2005	“Drosophila as a high-throughput model for studying fungal pathogenesis.” Texas-UK Biosciences Research Collaborative, London School of Tropical Health and Hygiene, London, UK.

2005	“Antifungal Susceptibility to guide empiric therapy” and “combination therapy.” AB Biodisk Antifungal Susceptibility Course, Stockholm, Sweden

2005	“Quinolone-Associated MRSA-Significant Papers in Infectious Diseases” American College of Clinical Pharmacy Annual Meeting, San Francisco, CA

2005	“Decisions Concerning the Use of Combination Antifungal Therapy.” American College of Clinical Pharmacy Annual Meeting, San Francisco, CA

2005	“Neutrophil subsets and Infection-New Insights into “Adaptable” Innate Immunity. MD. Anderson Infectious Diseases Grand Rounds

2005	“Management of Infection in the Immunocompromised Host” Merck Acute Care Sales Force National Training Symposium Jacksonville, FL

2005	“Combination Antifungal Therapy-Pro vs. Con” (with Melissa Johnson Pharm.D.) North Carolina Chapter of ACCP, Durham, NC

2005	“New Antifungals, New Treatment Options”
Louisiana State University Charity Hospital Infectious Diseases Grand Rounds

2005	“New Frontiers in the Treatment of Invasive Fungal Infections”
Making a Difference Pharmacy CE Conference, Carefree, AZ (with Ken Rolston, M.D.) Alabama Society of Health-System Pharmacists Annual Meeting, San Destin, FL New Orleans Society of Health System Pharmacists, New Orleans, LA

2005	“Do We Routinely Under-Dose Antifungal Therapy? New Insights into Dosage Escalation Strategies for Optimizing the PK/PD of Antifungal Therapy.” National Institute of Allergy and Infectious Diseases Grand Rounds, National Institutes of Health, Bethesda, MD

2005	“Toxigenic Moulds in Texas: New Insights into the Pathogenesis of an Opportunistic Pathogen.” The University of Tennessee College of Pharmacy, Memphis, TN


2004	“Practical Management of Multidrug Resistant Infections.” Session moderator. ASHP Annual Meeting, Orlando, FL
2004	“Evidence Surrounding Consensus Recommendations for Monitoring of Serum Vancomycin Levels. ASHP Annual Meeting, Orlando, FL
2004	“Case Studies in the Selection of Antifungal Therapy’ Division of Infectious Diseases, Henry Ford Hospital, Detroit, MI
2004	Research Seminar “Immunology of Effective Antifungal Therapy.” Wayne State College of Pharmacy, Detroit, MI
2004	“Overview of Antifungal Pharmacology,” “Antifungal Resistance,” “Combination Antifungal Therapy.” AB Biodisk Antifungal Susceptibility Course, Solna Sweden.
2004	“Pharmacotherapy of Invasive Fungal Infections” University of Connecticut School of Pharmacy ID Symposium, Storrs, CT
2004	“Treatment of Fungal Infection in the ICU Patient” New England Critical Care Pharmacy Symposium. Newton, MA
2004	“Newer Antifungal Therapies and Their Role in the Therapy of Invasive Mycoses” Pharmacy Society of Wisconsin Annual Meeting. Madison, WI
2004	“New Agents for The Perfect Storm of Infectious Diseases” Texas Society of Health Systems Annual Meeting. Houston, TX
2003	“Antifungal Therapy and Evidence-Based Medicine.” ASHP Annual Meeting, New Orleans, LA
2003	“The Perfect Storm In Infectious Diseases” ASHP Section of Clinical Specialists and Scientist Network Assembly. Moderator. ASHP Annual Meeting, New Orleans. LA
2003	“Antibiotic Selection in Gynecology-Oncology Patient. Gynecology-Oncology Grand Rounds. The University of Texas M.D. Anderson Cancer Center, Houston, TX
2003	“Significant Papers in Pharmacotherapy—SARS.” American College of Clinical Pharmacy Annual Meeting, Atlanta, GA
2003	“Menacing Moulds and New Antifungals.” Gulf Coast Society of Health-System Pharmacists, Houston, TX
2003	“Antifungal therapy consideration in the transplant patient.” Good Samaritan Hospital, Phoenix, AZ
2003	“Antifungal Resistance-Is the Fluconazole Era Over?” University of Missouri-Kansas City Infectious Diseases Symposium
2003	“Antifungal Resistance” Oklahoma Society of Health System Pharmacist Annual Meeting, Oklahoma City, OK
2003	Pharmacotherapy of Invasive Candidiasis, Citywide Pharmacy CE Conference. Denver, CO
2003	“Invasive Candidiasis” St. Lukes Hospital, Houston, TX
2003	“Menacing Moulds” Great Lakes CE Conference. Grand Rapids, MI
2002	“Echinocandins and Lipid AMB formulations.” Mycoses 2002 Symposia (given with Drs. Gerald Bodey, Dimitrios Kontoyiannis, and Issam Raad. Houston, TX.

2002-2006	“Beyond Microdilution Broth Antifungal Susceptibility Testing” Pre-symposium to the 41st, 42nd and 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Antifungal Susceptibility Testing for the Clinician. San Diego, CA, Chicago, Il, and Washington, D.C.

2002	Respiratory Infection Update. Texas Academy of Family Practice Physicians- Fall CME Symposium, Houston, TX

2002	“Management of Invasive Fungal Infections in the Critically Ill Patient.” Infectious Disease Pharmacotherapy CE Symposium, San Antonio, TX

2002	“New Agents and Evolving Strategies for Life-Threatening Fungal Infections in the Immunocompromised Patients.” Given with Dr. Dimitrios Kontoyiannis, M.D.). The 24th Annual M.D. Anderson Cancer Center Pharmacy Symposium on Cancer Chemotherapy. Houston, TX
2002	“Controversies in Antifungal Pharmacology,” Citywide ID conference. Seattle, WA
2002	Is Immunodysregulation a Virulence Factor for Aspergillus? Houston Area Mycoses Study Group. The University of Texas M.D. Anderson Cancer Center, Houston, TX
2002	The Immunology of Effective Antifungal Therapy- M.D. Anderson Cancer Center Infectious Diseases Research Conference, Houston TX.
2001	“New antifungal formulations, new antifungal targets”
-Grand Rounds, Fairfax Hospital, Fairfax, Virginia Baylor Medical Center, Dallas, Texas
-Texas Society of Health System Pharmacists, Annual Meeting Austin, Texas
-Kentucky Society of Health System Pharmacists, Annual Meeting Louisville, Kentucky
-Infectious Diseases Pharmacy Symposium, Albuquerque, New Mexico
-Infectious Diseases Citywide Symposium, Phoenix, Arizona
-Oklahoma Society of Health System Pharmacists, Tulsa OK

2001	“The Dilemma of Defining Optimal Treatment Strategies for Refractory Mycoses.” Satellite symposium Invasive Fungal Infections at the 2001 ACCP
Annual Meeting. Tampa, FL
2001	“New antibiotic update” Ft. Bend Physician Medical Society, Sugarland, TX
2001	“Pharmacology of Current and Future Antifungals” Infectious Diseases Morning Rounds, Barnes-Jewish Hospital at Washington University Medical Center,
St. Louis, MO.
2001	“Pharmacology of Current and Future Antifungals” at Mycoses 2001
(with Drs. John Rex, Richard Hamill, and Dimitrios Kontoyiannis), Houston, TX
2000	“New Antimicrobials for Resistant Gram-Positive Infections” Dallas, TX.
2000	“What is Considered Broad-Spectrum Therapy? A re-examination of the ATS Guidelines for Nosocomial Pneumonia” Memorial Southwest Hospital (Baylor) Grand Rounds, Houston, TX
2000	“Controversies in the Management of Invasive Fungal Infections.”
Presented: -Southwestern Med. School Infect. Dis. Grand Rounds, Dallas, Texas

Grand Rounds, Wilford Hall Medical Center, San Antonio, TX
Clinical Updates 2000- Annual Meeting of the California Society of Health System Pharmacists, Palm Springs, CA.
Winter CE meeting of the Southern Colorado Society of Health System Pharmacists, Colorado Springs, CO
Grand Rounds, Memorial Southeast Medical Center, Houston, TX

2000	“New Antimicrobials for the Post-Antibiotic Era” UH Infectious Diseases Continuing Education Symposium, Texas Medical Center Marriott Hotel, Houston, Texas

2000	“Are We Nearing the End of the Fluconazole Era?” Advances in Oncology Institutional Grand Rounds. M.D. Anderson Cancer Center (Given with Drs. Gerald Bodey and Issam Raad). Houston, TX

2000	“Antifungal Pharmacodynamics” M.D. Anderson Infectious Diseases Research Conference, Houston TX.

2000	“Differentiating the Quinolones-Do we really need new agents?”
-Resident Grand Rounds, Corpus Christi, TX
-Houston Area Society of Otolaryngologists, Houston, TX.

2000	“Implications of Streptococcal Resistance for Antibiotic Therapy” Border Issues and Resistance, University of Texas CME Otolaryngology Conference. McAllen TX

1999	“Antifungal Pharmacodynamics-What Emerging Data Are Telling Us About Dosing Antifungal Therapy.” Visiting Professor Series; Department of Pharmacological and Pharmaceutical Sciences. UH College of Pharmacy. Houston, TX

1999	“Should Combinations of Amphotericin B and Fluconazole Be Used for the Treatment of Candidemia?” University of Wisconsin College of Pharmacy.

1998	“IDSA Guidelines for the Treatment of Community Acquired Pneumonia-
Resistant S. pneumoniae and the Role of Quinolones.” Fellowship Forum. University of Iowa, Iowa City, IA

1997	Pharmacodynamic Evaluation of Combination Amphotericin B-Fluconazole Activity Using an In Vitro Infection Model.” Fellow Seminar Series. University of Iowa. Iowa City, IA

1997		“Evolving Role of Oral Antimicrobial Therapy” Pulmonology Conference Series. Barnes-Jewish Hospital. Washington University Medical School.
St. Louis, MO

1996	“Rational Use of Step-Down Oral Antibiotic Therapy” Pharmacists Continuing Education. Barnes- Jewish Hospital, St. Louis, MO

1997	“Evaluation of Colony Stimulating Factor Use in a Large Teaching Hospital” Midwest Residency Conference, Memphis, TN

1996	“Colony Stimulating Factors as Adjunctive Treatment in Acute Myelogenous Leukemia.” Residency Seminar Series. St. Louis, MO

1995	“Continuous infusion dosing strategy to overcome diuretic resistance” Doctor of Pharmacy Seminar. University of Kansas Medical Center.



## Publications

Scopus author ID: 7404846664 <br>
_H_ index 71; 15,511 citations <br>

1. Brüggemann, R.J., Verheggen, R., Boerrigter, E., Stanzani, M., Verweij, P.E., Blijlevens, N.M.A., Lewis, R.E. Management of drug–drug interactions of targeted therapies for haematological malignancies and triazole antifungal drugs (2022) The Lancet Haematology, 9 (1), pp. e58-e72. DOI: 10.1016/S2352-3026(21)00232-5

2. Bartoletti, M., Pascale, R., Cricca, M., Rinaldi, M., Maccaro, A., Bussini, L., Fornaro, G., Tonetti, T., Pizzilli, G., Francalanci, E., Giuntoli, L., Rubin, A., Moroni, A., Ambretti, S., Trapani, F., Vatamanu, O., Ranieri, V.M., Castelli, A., Baiocchi, M., Lewis, R., Giannella, M., Viale, P., PREDICO Study Group Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study (2021) Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73 (11), pp. e3606-e3614. DOI: 10.1093/cid/ciaa1065

Gaibani, P., Viciani, E., Bartoletti, M., Lewis, R.E., Tonetti, T., Lombardo, D., Castagnetti, A., Bovo, F., Horna, C.S., Ranieri, M., Viale, P., Re, M.C., Ambretti, S.
The lower respiratory tract microbiome of critically ill patients with COVID-19
(2021) Scientific Reports, 11 (1), art. no. 10103, . 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85105823276&doi=10.1038%2fs41598-021-89516-6&partnerID=40&md5=965e3fd897f9094b635c51df18059688

DOI: 10.1038/s41598-021-89516-6

Johnson, M.D., Lewis, R.E., Dodds Ashley, E.S., Perfect, J.R., Kontoyiannis, D.P.
Reply to Day et al
(2021) Journal of Infectious Diseases, 224 (9), pp. 1627-1628. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112141808&doi=10.1093%2finfdis%2fjiab183&partnerID=40&md5=6195041be5cf92462cf153aaed9e93d7

DOI: 10.1093/infdis/jiab183

Stanzani, M., Sassi, C., Lewis, R., Sartor, C., Rasetto, G., Cavo, M., Battista, G.
Early low-dose computed tomography with pulmonary angiography to improve the early diagnosis of invasive mould disease in patients with haematological malignancies: A pilot study
(2021) Journal of Infection, 83 (3), pp. 371-380. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85110424023&doi=10.1016%2fj.jinf.2021.06.019&partnerID=40&md5=4db6e5bcd1c88683e06859a4b0d62c56

DOI: 10.1016/j.jinf.2021.06.019

Giannella, M., Freire, M., Rinaldi, M., Abdala, E., Rubin, A., Mularoni, A., Gruttadauria, S., Grossi, P., Shbaklo, N., Tandoi, F., Ferrarese, A., Burra, P., Fernandes, R., Aranha Camargo, L.F., Asensio, A., Alagna, L., Bandera, A., Simkins, J., Abbo, L., Halpern, M., Santana Girao, E., Valerio, M., Muñoz, P., Fernandez Yunquera, A., Statlender, L., Yahav, D., Franceschini, E., Graziano, E., Morelli, M.C., Cescon, M., Viale, P., Lewis, R., Bartoletti, M., Pascale, R., Campoli, C., Coladonato, S., Cristini, F., Tumietto, F., Siniscalchi, A., Laici, C., Ambretti, S., Romagnoli, R., De Rosa, F.G., Muscatello, A., Mangioni, D., Gori, A., Antonelli, B., Dondossola, D., Rossi, G., Invernizzi, F., Peghin, M., Cillo, U., Mussini, C., Benedetto, F.D., Terrabuio, D.R.B., Bittante, C.D., Toniolo, A.D.R., Balbi, E., Garcia, J.H.P., Morrás, I., Ramos, A., Cruz, A.F., Salcedo, M.
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study
(2021) Clinical Infectious Diseases, 73 (4), pp. E955-E966. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85114350736&doi=10.1093%2fcid%2fciab109&partnerID=40&md5=fb590514c38a36e2b17949acb9f78be5

DOI: 10.1093/cid/ciab109

Lewis, R.E., Andes, D.R.
Managing uncertainty in antifungal dosing: antibiograms, therapeutic drug monitoring and drug-drug interactions
(2021) Current opinion in infectious diseases, 34 (4), pp. 288-296. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112119329&doi=10.1097%2fQCO.0000000000000740&partnerID=40&md5=75b6a85f0ac48409bdc3b5a2ed7f7346

DOI: 10.1097/QCO.0000000000000740

Verweij, P.E., Brüggemann, R.J.M., Azoulay, E., Bassetti, M., Blot, S., Buil, J.B., Calandra, T., Chiller, T., Clancy, C.J., Cornely, O.A., Depuydt, P., Koehler, P., Lagrou, K., de Lange, D., Lass-Flörl, C., Lewis, R.E., Lortholary, O., Liu, P.-W.L., Maertens, J., Nguyen, M.H., Patterson, T.F., Rijnders, B.J.A., Rodriguez, A., Rogers, T.R., Schouten, J.A., Wauters, J., van de Veerdonk, F.L., Martin-Loeches, I.
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis
(2021) Intensive Care Medicine, 47 (8), pp. 819-834. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85108592486&doi=10.1007%2fs00134-021-06449-4&partnerID=40&md5=561e264bfde5d64713335d3d127fba50

DOI: 10.1007/s00134-021-06449-4

Rinaldi, M., Bartoletti, M., Ferrarese, A., Franceschini, E., Campoli, C., Coladonato, S., Pascale, R., Tedeschi, S., Gatti, M., Cricca, M., Ambretti, S., Siniscalchi, A., Morelli, M.C., Cescon, M., Cillo, U., Di Benedetto, F., Burra, P., Mussini, C., Cristini, F., Lewis, R., Viale, P., Giannella, M.
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study
(2021) Transplant Infectious Disease, 23 (4), art. no. e13608, . 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85104105216&doi=10.1111%2ftid.13608&partnerID=40&md5=e859f278a5e08cf4c9ea85b7b86c87e0

DOI: 10.1111/tid.13608

Glampedakis, E., Cassaing, S., Fekkar, A., Dannaoui, E., Bougnoux, M.-E., Bretagne, S., Neofytos, D., Schreiber, P.W., Hennequin, C., Morio, F., Shadrivova, O., Bongomin, F., Fernández-Ruiz, M., Bellanger, A.P., Arikan-Akdagli, S., Erard, V., Aigner, M., Paolucci, M., Khanna, N., Charpentier, E., Bonnal, C., Brun, S., Gabriel, F., Riat, A., Zbinden, R., Le Pape, P., Klimko, N., Lewis, R.E., Richardson, M., İnkaya, A.C., Coste, A.T., Bochud, P.-Y., Lamoth, F.
Invasive Aspergillosis Due to Aspergillus Section Usti: A Multicenter Retrospective Study
(2021) Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 72 (8), pp. 1379-1385. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85105764528&doi=10.1093%2fcid%2fciaa230&partnerID=40&md5=80aead4fb04e8cdd83a20d087365e378

DOI: 10.1093/cid/ciaa230

Axell-House, D.B., Wurster, S., Jiang, Y., Kyvernitakis, A., Lewis, R.E., Tarrand, J.J., Raad, I.I., Kontoyiannis, D.P.
Breakthrough mucormycosis developing on mucorales-active antifungals portrays a poor prognosis in patients with hematologic cancer
(2021) Journal of Fungi, 7 (3), art. no. 217, . 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103604288&doi=10.3390%2fjof7030217&partnerID=40&md5=2106ba334dd113af75fbf7ab4e75776e

DOI: 10.3390/jof7030217

Gudiol, C., Lewis, R.E., Strati, P., Kontoyiannis, D.P.
Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?
(2021) The Lancet Haematology, 8 (3), pp. e216-e228. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100083313&doi=10.1016%2fS2352-3026%2820%2930376-8&partnerID=40&md5=26b61b5afabf45f1f99cb5fbcad3ff69

DOI: 10.1016/S2352-3026(20)30376-8

Pascale, R., Bussini, L., Gaibani, P., Bovo, F., Fornaro, G., Lombardo, D., Ambretti, S., Pensalfine, G., Appolloni, L., Bartoletti, M., Tedeschi, S., Tumietto, F., Lewis, R., Viale, P., Giannella, M.
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study
(2021) Infection Control and Hospital Epidemiology, . 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85104350650&doi=10.1017%2fice.2021.144&partnerID=40&md5=21a8b987a8407cf6fd898ca0e4d3da8e

DOI: 10.1017/ice.2021.144

Lamoth, F., Lewis, R.E., Kontoyiannis, D.P.
Role and interpretation of antifungal susceptibility testing for the management of invasive fungal infections
(2021) Journal of Fungi, 7 (1), art. no. 17, pp. 1-21. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85098879711&doi=10.3390%2fjof7010017&partnerID=40&md5=dec465c15eaaba886b281deb5fba263e

DOI: 10.3390/jof7010017

Coppola, P.E., Gaibani, P., Sartor, C., Ambretti, S., Lewis, R.E., Sassi, C., Pignatti, M., Paolini, S., Curti, A., Castagnetti, F., Ursi, M., Cavo, M., Stanzani, M.
Ceftolozane-tazobactam treatment of hypervirulent multidrug resistant pseudomonas aeruginosa infections in neutropenic patients
(2020) Microorganisms, 8 (12), art. no. 2055, pp. 1-11. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85098241217&doi=10.3390%2fmicroorganisms8122055&partnerID=40&md5=e3bed10e045bc56df774e26abb01c81f

DOI: 10.3390/microorganisms8122055

Bartoletti, M., Baldassarre, M., Domenicali, M., Lewis, R.E., Giannella, M., Antognoli, A., Rinaldi, M., Zaccherini, G., Verucchi, G., Marconi, L., Tamè, M., Berardi, S., Napoli, L., Siniscalchi, A., Fabbri, A., Biselli, M., Tufoni, M., Pavarin, R.M., Trevisani, F., Viale, P., Bernardi, M., Caraceni, P.
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study
(2020) Open Forum Infectious Diseases, 7 (11), . 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85096771368&doi=10.1093%2fofid%2fofaa453&partnerID=40&md5=eb9c789d0e1a7532f0093bf8a4726b5d

DOI: 10.1093/ofid/ofaa453

Garcia-Vidal, C., Lewis, R.E., Kontoyiannis, D.P.
Combination antifungal therapy for breakthrough invasive mould disease in patients with haematological malignancies: When management reasoning eclipses evidence-based medicine
(2020) Journal of Antimicrobial Chemotherapy, 75 (11), pp. 3096-3098. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85093539329&doi=10.1093%2fjac%2fdkaa281&partnerID=40&md5=363bd71728b45def4548325f80c806c7

DOI: 10.1093/jac/dkaa281

Lewis, R.E., Kontoyiannis, D.P.
Chimeric antigen receptor T-cell immunotherapy and need for prophylaxis for invasive mold infections
(2020) Clinical Infectious Diseases, 71 (7), pp. 1802-1803. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85094684697&doi=10.1093%2fcid%2fciaa031&partnerID=40&md5=929748ebcee14013b79b50e2413dbe58

DOI: 10.1093/cid/ciaa031

Zaghi, I., Gaibani, P., Campoli, C., Bartoletti, M., Giannella, M., Ambretti, S., Viale, P., Lewis, R.E.
Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections
(2020) Clinical Microbiology and Infection, 26 (10), pp. 1338-1344. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086569762&doi=10.1016%2fj.cmi.2020.04.036&partnerID=40&md5=fbd7fa6c02695cc037353fa1ffa32b0c

DOI: 10.1016/j.cmi.2020.04.036

Fernández-Cruz, A., Lewis, R.E., Kontoyiannis, D.P.
How long do we need to treat an invasive mold disease in hematology patients? factors influencing duration of therapy and future questions
(2020) Clinical Infectious Diseases, 71 (3), pp. 685-692. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088850461&doi=10.1093%2fcid%2fciz1195&partnerID=40&md5=17a8c99b6e764e5f1b48cbe3c4726f4d

DOI: 10.1093/cid/ciz1195

Verweij, P.E., Rijnders, B.J.A., Brüggemann, R.J.M., Azoulay, E., Bassetti, M., Blot, S., Calandra, T., Clancy, C.J., Cornely, O.A., Chiller, T., Depuydt, P., Giacobbe, D.R., Janssen, N.A.F., Kullberg, B.-J., Lagrou, K., Lass-Flörl, C., Lewis, R.E., Liu, P.W.-L., Lortholary, O., Maertens, J., Martin-Loeches, I., Nguyen, M.H., Patterson, T.F., Rogers, T.R., Schouten, J.A., Spriet, I., Vanderbeke, L., Wauters, J., van de Veerdonk, F.L.
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
(2020) Intensive Care Medicine, 46 (8), pp. 1524-1535. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086790066&doi=10.1007%2fs00134-020-06091-6&partnerID=40&md5=d80dbf107a90662b263e7895c417c996

DOI: 10.1007/s00134-020-06091-6

Giannella, M., Pascale, R., Pancaldi, L., Monari, C., Ianniruberto, S., Malosso, P., Bussini, L., Bartoletti, M., Tedeschi, S., Ambretti, S., Lewis, R., Viale, P.
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study
(2020) Clinical Microbiology and Infection, 26 (7), pp. 897-903. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079896461&doi=10.1016%2fj.cmi.2020.01.023&partnerID=40&md5=71784eb22052b11319dc89c58f59fc07

DOI: 10.1016/j.cmi.2020.01.023

Tolomelli, G., Mancuso, K., Tacchetti, P., Patriarca, F., Galli, M., Pantani, L., Zannetti, B., Motta, M.R., Rizzi, S., Dan, E., Sinigaglia, B., Giudice, V., Olmo, A., Arpinati, M., Chirumbolo, G., Fanin, R., Lewis, R.E., Paris, L., Bonifazi, F., Cavo, M., Curti, A., Lemoli, R.M.
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma
(2020) Bone Marrow Transplantation, 55 (5), pp. 946-954. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075422010&doi=10.1038%2fs41409-019-0756-1&partnerID=40&md5=57f0e21001c6ddd6c226f2990a1b4a03

DOI: 10.1038/s41409-019-0756-1

Lewis, R.E., Kontoyiannis, D.P.
Infectious disease consultation for candidaemia
(2020) The Lancet Infectious Diseases, 20 (2), p. 164. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078264430&doi=10.1016%2fS1473-3099%2819%2930682-6&partnerID=40&md5=60320c50bb587d139b427cbac648e858

DOI: 10.1016/S1473-3099(19)30682-6

Johnson, M.D., Lewis, R.E., Dodds Ashley, E.S., Ostrosky-Zeichner, L., Zaoutis, T., Thompson, G.R., III, Andes, D.R., Walsh, T.J., Pappas, P.G., Cornely, O.A., Perfect, J.R., Kontoyiannis, D.P.
Core recommendations for antifungal stewardship: a statement of the mycoses study group education and research consortium
(2020) Journal of Infectious Diseases, 222, pp. S175-S198. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089170822&doi=10.1093%2fINFDIS%2fJIAA394&partnerID=40&md5=cb5fbd99b55fdbee7bf68c461f538e0a

DOI: 10.1093/INFDIS/JIAA394

Giannella, M., Bussini, L., Pascale, R., Bartoletti, M., Malagrinò, M., Pancaldi, L., Toschi, A., Ferraro, G., Marconi, L., Ambretti, S., Lewis, R., Viale, P.
Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections
(2019) Open Forum Infectious Diseases, 6 (12), . 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079197874&doi=10.1093%2fofid%2fofz505&partnerID=40&md5=06ee80ec6d801f44016c34184477e382

DOI: 10.1093/ofid/ofz505

Cornely, O.A., Alastruey-Izquierdo, A., Arenz, D., Chen, S.C.A., Dannaoui, E., Hochhegger, B., Hoenigl, M., Jensen, H.E., Lagrou, K., Lewis, R.E., Mellinghoff, S.C., Mer, M., Pana, Z.D., Seidel, D., Sheppard, D.C., Wahba, R., Akova, M., Alanio, A., Al-Hatmi, A.M.S., Arikan-Akdagli, S., Badali, H., Ben-Ami, R., Bonifaz, A., Bretagne, S., Castagnola, E., Chayakulkeeree, M., Colombo, A.L., Corzo-León, D.E., Drgona, L., Groll, A.H., Guinea, J., Heussel, C.-P., Ibrahim, A.S., Kanj, S.S., Klimko, N., Lackner, M., Lamoth, F., Lanternier, F., Lass-Floerl, C., Lee, D.-G., Lehrnbecher, T., Lmimouni, B.E., Mares, M., Maschmeyer, G., Meis, J.F., Meletiadis, J., Morrissey, C.O., Nucci, M., Oladele, R., Pagano, L., Pasqualotto, A., Patel, A., Racil, Z., Richardson, M., Roilides, E., Ruhnke, M., Seyedmousavi, S., Sidharthan, N., Singh, N., Sinko, J., Skiada, A., Slavin, M., Soman, R., Spellberg, B., Steinbach, W., Tan, B.H., Ullmann, A.J., Vehreschild, J.J., Vehreschild, M.J.G.T., Walsh, T.J., White, P.L., Wiederhold, N.P., Zaoutis, T., Chakrabarti, A., Mucormycosis ECMM MSG Global Guideline Writing Group
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
(2019) The Lancet Infectious Diseases, 19 (12), pp. e405-e421. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075522537&doi=10.1016%2fS1473-3099%2819%2930312-3&partnerID=40&md5=2d02c25b2475005a6b2ff2072ab58cdc

DOI: 10.1016/S1473-3099(19)30312-3

Stanzani, M., Cricca, M., Sassi, C., Sutto, E., De Cicco, G., Bonifazi, F., Bertuzzi, C., Bacci, F., Paolini, S., Cavo, M., Lewis, R.E.
Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature
(2019) Mycoses, 62 (12), pp. 1100-1107. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074371915&doi=10.1111%2fmyc.12978&partnerID=40&md5=bcd4ed86a1537975aee346b82c7519b1

DOI: 10.1111/myc.12978

Welte, T., Len, O., Muñoz, P., Romani, L., Lewis, R., Perrella, A.
Invasive mould infections in solid organ transplant patients: modifiers and indicators of disease and treatment response
(2019) Infection, 47 (6), pp. 919-927. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073931229&doi=10.1007%2fs15010-019-01360-z&partnerID=40&md5=233e9b69e964279f1cc26ce6005d8a52

DOI: 10.1007/s15010-019-01360-z

Giannella, M., Bartoletti, M., Campoli, C., Rinaldi, M., Coladonato, S., Pascale, R., Tedeschi, S., Ambretti, S., Cristini, F., Tumietto, F., Siniscalchi, A., Bertuzzo, V., Morelli, M.C., Cescon, M., Pinna, A.D., Lewis, R., Viale, P.
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study
(2019) Clinical Microbiology and Infection, 25 (12), pp. 1525-1531. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066092464&doi=10.1016%2fj.cmi.2019.04.014&partnerID=40&md5=c43dbef84ae00fe1ba5cc6cb32adfa1c

DOI: 10.1016/j.cmi.2019.04.014

Bartoletti, M., Giannella, M., Lewis, R.E., Caraceni, P., Tedeschi, S., Paul, M., Schramm, C., Bruns, T., Merli, M., Cobos-Trigueros, N., Seminari, E., Retamar, P., Muñoz, P., Tumbarello, M., Burra, P., Cerenzia, M.T., Barsic, B., Calbo, E., Maraolo, A.E., Petrosillo, N., Galan-Ladero, M.A., D'Offizi, G., Zak-Doron, Y., Rodriguez-Baño, J., Baldassarre, M., Verucchi, G., Domenicali, M., Bernardi, M., Viale, P., ESGBIS/BICHROME study group
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: An observational multicenter study
(2019) Clinical Infectious Diseases, 69 (10), pp. 1731-1739. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069655554&doi=10.1093%2fcid%2fciz032&partnerID=40&md5=4433f4ee5d23def8b735de625d5fdc01

DOI: 10.1093/cid/ciz032

Lewis, R.E., Wurster, S., Beyda, N.D., Albert, N.D., Kontoyiannis, D.P.
Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis
(2019) Diagnostic Microbiology and Infectious Disease, 95 (3), art. no. 114861, . 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070720138&doi=10.1016%2fj.diagmicrobio.2019.06.013&partnerID=40&md5=b51f9f1b9201ccb8cbc7cc6b62d13fbc

DOI: 10.1016/j.diagmicrobio.2019.06.013

Gaibani, P., Lombardo, D., Bartoletti, M., Ambretti, S., Campoli, C., Giannella, M., Tedeschi, S., Conti, M., Mancini, R., Landini, M.P., Re, M.C., Viale, P., Lewis, R.E.
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae
(2019) European Journal of Clinical Microbiology and Infectious Diseases, 38 (10), pp. 1925-1931. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068863387&doi=10.1007%2fs10096-019-03628-6&partnerID=40&md5=2e7c699a80abf34f57da8bb98d4999be

DOI: 10.1007/s10096-019-03628-6

Stanzani, M., Sassi, C., Battista, G., Lewis, R.E.
Beyond biomarkers: How enhanced CT imaging can improve the diagnostic-driven management of invasive mould disease
(2019) Medical Mycology, 57, pp. S274-S286. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069561064&doi=10.1093%2fmmy%2fmyy125&partnerID=40&md5=4a620117a4a5b17d38367e896931132a

DOI: 10.1093/mmy/myy125

Stanzani, M., Vianelli, N., Cavo, M., Kontoyiannis, D.P., Lewis, R.E.
Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies
(2019) Journal of Infection, 78 (6), pp. 484-490. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064233492&doi=10.1016%2fj.jinf.2019.04.002&partnerID=40&md5=8fed4d4628ca4fe25de7b9db13d5d8de

DOI: 10.1016/j.jinf.2019.04.002

Walsh, T.J., Lewis, R.E., Adler-Moore, J.
Pharmacology of Liposomal Amphotericin B: An Introduction to Preclinical and Clinical Advances for Treatment of Life-threatening Invasive Fungal Infections
(2019) Clinical Infectious Diseases, 68, pp. S241-S243. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068493841&doi=10.1093%2fcid%2fciz091&partnerID=40&md5=cf166b22ce46b1b9fcc41e371c901e34

DOI: 10.1093/cid/ciz091

Groll, A.H., Rijnders, B.J.A., Walsh, T.J., Adler-Moore, J., Lewis, R.E., Brüggemann, R.J.M.
Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B
(2019) Clinical Infectious Diseases, 68, pp. S260-S274. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068492597&doi=10.1093%2fcid%2fciz076&partnerID=40&md5=3273008f6b1da30deec6a9eb9f76563d

DOI: 10.1093/cid/ciz076

Adler-Moore, J., Lewis, R.E., Brüggemann, R.J.M., Rijnders, B.J.A., Groll, A.H., Walsh, T.J.
Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B
(2019) Clinical Infectious Diseases, 68, pp. S244-S259. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068491703&doi=10.1093%2fcid%2fciz064&partnerID=40&md5=92042395a6d71346e32251e442195995

DOI: 10.1093/cid/ciz064

Wurster, S., Kumaresan, P.R., Albert, N.D., Hauser, P.J., Lewis, R.E., Kontoyiannis, D.P.
Live monitoring and analysis of fungal growth, viability, and mycelial morphology using the incucyte neurotrack processing module
(2019) mBio, 10 (3), art. no. e00673-19, . 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85067188427&doi=10.1128%2fmBio.00673-19&partnerID=40&md5=002851299bfb1461b0c568e5680837b7

DOI: 10.1128/mBio.00673-19

Giannella, M., Pascale, R., Ferraro, G., Toschi, A., Pancaldi, L., Furii, F., Bartoletti, M., Tedeschi, S., Ambretti, S., Lewis, R.E., Viale, P.
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study
(2019) International Journal of Antimicrobial Agents, 53 (5), pp. 574-581. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063027123&doi=10.1016%2fj.ijantimicag.2019.01.005&partnerID=40&md5=ebc7b64e7ecee7265a5757c2a360ea3b

DOI: 10.1016/j.ijantimicag.2019.01.005

Wurster, S., Lewis, R.E., Albert, N.D., Kontoyiannis, D.P.
Preexposure to Isavuconazole Increases the Virulence of Mucorales but Not Aspergillus fumigatus in a Drosophila melanogaster Infection Model
(2019) Antimicrobial Agents and Chemotherapy, 63 (2), art. no. e01896-18, . 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060801890&doi=10.1128%2fAAC.01896-18&partnerID=40&md5=85eca823f14b4f129263a0ead18b0558

DOI: 10.1128/AAC.01896-18

Lewis, R.E., Kontoyiannis, D.P., Viale, P., Sarpong, E.M.
Using state transition models to explore how the prevalence of subtherapeutic posaconazole exposures impacts the clinical utility of therapeutic drug monitoring for posaconazole tablets and oral suspension
(2019) Antimicrobial Agents and Chemotherapy, 63 (12), art. no. e01435-19, . 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075675645&doi=10.1128%2fAAC.01435-19&partnerID=40&md5=8a5d92b45ce3a4015da28f45d360acb0

DOI: 10.1128/AAC.01435-19

Zoran, T., Sartori, B., Sappl, L., Aigner, M., Sánchez-Reus, F., Rezusta, A., Chowdhary, A., Taj-Aldeen, S.J., Arendrup, M.C., Oliveri, S., Kontoyiannis, D.P., Alastruey-Izquierdo, A., Lagrou, K., Lo Cascio, G., Meis, J.F., Buzina, W., Farina, C., Drogari-Apiranthitou, M., Grancini, A., Tortorano, A.M., Willinger, B., Hamprecht, A., Johnson, E., Klingspor, L., Arsic-Arsenijevic, V., Cornely, O.A., Meletiadis, J., Prammer, W., Tullio, V., Vehreschild, J.-J., Trovato, L., Lewis, R.E., Segal, E., Rath, P.-M., Hamal, P., Rodriguez-Iglesias, M., Roilides, E., Arikan-Akdagli, S., Chakrabarti, A., Colombo, A.L., Fernández, M.S., Martin-Gomez, M.T., Badali, H., Petrikkos, G., Klimko, N., Heimann, S.M., Uzun, O., Roudbary, M., De La Fuente, S., Houbraken, J., Risslegger, B., Sabino, R., Lass-Flörl, C., Lackner, M.
Corrigendum: Azole-resistance in aspergillus terreusand related species: An emerging problem or a rare phenomenon? (Frontiers in Microbiology (2018) 9 (516) DOI: 10.3389/fmicb.2018.00516)
(2019) Frontiers in Microbiology, 10 (JAN), art. no. 3245, . 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064392014&doi=10.3389%2ffmicb.2018.03245&partnerID=40&md5=8115322585a02a54b08e69f651262f0d

DOI: 10.3389/fmicb.2018.03245

Stanzani, M., Lewis, R.E.
Development and applications of prognostic risk models in the management of invasive mold disease
(2018) Journal of Fungi, 4 (4), art. no. 141, . 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061642234&doi=10.3390%2fjof4040141&partnerID=40&md5=ccad1564193e1af2a29b7718dcd17784

DOI: 10.3390/jof4040141

Lionakis, M.S., Lewis, R.E., Kontoyiannis, D.P.
Breakthrough invasive mold infections in the hematology patient: Current concepts and future directions
(2018) Clinical Infectious Diseases, 67 (10), pp. 1621-1630. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055638536&doi=10.1093%2fcid%2fciy473&partnerID=40&md5=038dd344693d7e39c894543c1b230124

DOI: 10.1093/cid/ciy473

Giannella, M., Paolucci, M., Roncarati, G., Vandi, G., Pascale, R., Trapani, F., Bartoletti, M., Tedeschi, S., Ambretti, S., Lewis, R., Re, M.C., Viale, P.
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: A pilot single-centre study
(2018) Journal of Antimicrobial Chemotherapy, 73 (10), pp. 2856-2859. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061174340&doi=10.1093%2fjac%2fdky247&partnerID=40&md5=a22911f0f477ac2c7fdd1309ec1cfe0a

DOI: 10.1093/jac/dky247

Giannella, M., Pascale, R., Toschi, A., Ferraro, G., Graziano, E., Furii, F., Bartoletti, M., Tedeschi, S., Ambretti, S., Lewis, R.E., Viale, P.
Treatment duration for Escherichia coli bloodstream infection and outcomes: retrospective single-centre study
(2018) Clinical Microbiology and Infection, 24 (10), pp. 1077-1083. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042192088&doi=10.1016%2fj.cmi.2018.01.013&partnerID=40&md5=5c728f996130df8854604197def547d0

DOI: 10.1016/j.cmi.2018.01.013

Fernandez, I.J., Crocetta, F.M., Demattè, M., Farneti, P., Stanzani, M., Lewis, R.E., Fornaciari, M., Pasquini, E., Sciarretta, V.
Acute Invasive Fungal Rhinosinusitis in Immunocompromised Patients: Role of an Early Diagnosis
(2018) Otolaryngology - Head and Neck Surgery (United States), 159 (2), pp. 386-393. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045307033&doi=10.1177%2f0194599818765744&partnerID=40&md5=32d6dfdd6dcb9c0c11127204f8777d68

DOI: 10.1177/0194599818765744

Gaibani, P., Campoli, C., Lewis, R.E., Volpe, S.L., Scaltriti, E., Giannella, M., Pongolini, S., Berlingeri, A., Cristini, F., Bartoletti, M., Tedeschi, S., Ambretti, S.
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment
(2018) Journal of Antimicrobial Chemotherapy, 73 (6), pp. 1525-1529. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048120125&doi=10.1093%2fjac%2fdky082&partnerID=40&md5=f56bd7006ab6c7078fc735f0120a40bd

DOI: 10.1093/jac/dky082

Ullmann, A.J., Aguado, J.M., Arikan-Akdagli, S., Denning, D.W., Groll, A.H., Lagrou, K., Lass-Flörl, C., Lewis, R.E., Munoz, P., Verweij, P.E., Warris, A., Ader, F., Akova, M., Arendrup, M.C., Barnes, R.A., Beigelman-Aubry, C., Blot, S., Bouza, E., Brüggemann, R.J.M., Buchheidt, D., Cadranel, J., Castagnola, E., Chakrabarti, A., Cuenca-Estrella, M., Dimopoulos, G., Fortun, J., Gangneux, J.-P., Garbino, J., Heinz, W.J., Herbrecht, R., Heussel, C.P., Kibbler, C.C., Klimko, N., Kullberg, B.J., Lange, C., Lehrnbecher, T., Löffler, J., Lortholary, O., Maertens, J., Marchetti, O., Meis, J.F., Pagano, L., Ribaud, P., Richardson, M., Roilides, E., Ruhnke, M., Sanguinetti, M., Sheppard, D.C., Sinkó, J., Skiada, A., Vehreschild, M.J.G.T., Viscoli, C., Cornely, O.A.
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
(2018) Clinical Microbiology and Infection, 24, pp. e1-e38. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043449929&doi=10.1016%2fj.cmi.2018.01.002&partnerID=40&md5=3ecc9181915aabd585c4609c0e35c78a

DOI: 10.1016/j.cmi.2018.01.002

Di Blasi, R., Cattaneo, C., Lewis, R.E., Tumbarello, M., Angelici, L., Dragonetti, G., Busca, A., Cambò, B., Candoni, A., Cesarini, M., Cesaro, S., Delia, M., Fanci, R., Farina, F., Garzia, M., Giordano, A., Martino, B., Melillo, L., Nadali, G., Perriello, V., Picardi, M., Quinto, A.M., Salutari, P., Spolzino, A., Vacca, A., Vetro, C., Zancanella, M., Nosari, A., Aversa, F., Pagano, L., on the behalf of the SEIFEM group (Sorveglianza Epidemiologica Infezioni Fungine in Ematologia)
Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL)
(2018) Annals of Hematology, 97 (5), pp. 791-798. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041597453&doi=10.1007%2fs00277-018-3252-6&partnerID=40&md5=0cc54f39dee88866a196409809bdbbd9

DOI: 10.1007/s00277-018-3252-6

Bartoletti, M., Giannella, M., Lewis, R., Caraceni, P., Tedeschi, S., Paul, M., Schramm, C., Bruns, T., Merli, M., Cobos-Trigueros, N., Seminari, E., Retamar, P., Muñoz, P., Tumbarello, M., Burra, P., Torrani Cerenzia, M., Barsic, B., Calbo, E., Maraolo, A.E., Petrosillo, N., Galan-Ladero, M.A., D'Offizi, G., Bar Sinai, N., Rodríguez-Baño, J., Verucchi, G., Bernardi, M., Viale, P., Campoli, C., Siccardi, G., Ambretti, S., Stallmach, A., Venditti, M., Lucidi, C., Ludovisi, S., De Cueto, M., Navarro, M.D., Lopez Cortes, E., Bouza, E., Valerio, M., Eworo, A., Losito, R., Senzolo, M., Nadal, E., Ottobrelli, A., Varguvic, M., Badia, C., Borgia, G., Gentile, I., Buonomo, A.R., Boumis, E., Beteta-Lopez, A., Rianda, A., Taliani, G., Grieco, S., ESGBIS/BICHROME Study Group
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients
(2018) Clinical Microbiology and Infection, 24 (5), pp. 546.e1-546.e8. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029770571&doi=10.1016%2fj.cmi.2017.08.001&partnerID=40&md5=1426fff376026ca3f647d3b71c3ea4b2

DOI: 10.1016/j.cmi.2017.08.001

Tam, V.H., Pérez, C., Ledesma, K.R., Lewis, R.E.
Transcriptional profiles of pulmonary innate immune responses to isogenic antibiotic-susceptible and multidrug-resistant Pseudomonas aeruginosa
(2018) Microbiology and Immunology, 62 (4), pp. 291-294. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044433514&doi=10.1111%2f1348-0421.12581&partnerID=40&md5=e8352a1a370e83736c05eded69aadaeb

DOI: 10.1111/1348-0421.12581

Zoran, T., Sartori, B., Sappl, L., Aigner, M., Sánchez-Reus, F., Rezusta, A., Chowdhary, A., Taj-Aldeen, S.J., Arendrup, M.C., Oliveri, S., Kontoyiannis, D.P., Alastruey-Izquierdo, A., Lagrou, K., Cascio, G.L., Meis, J.F., Buzina, W., Farina, C., Drogari-Apiranthitou, M., Grancini, A., Tortorano, A.M., Willinger, B., Hamprecht, A., Johnson, E., Klingspor, L., Arsic-Arsenijevic, V., Cornely, O.A., Meletiadis, J., Prammer, W., Tullio, V., Vehreschild, J.-J., Trovato, L., Lewis, R.E., Segal, E., Rath, P.-M., Hamal, P., Rodriguez-Iglesias, M., Roilides, E., Arikan-Akdagli, S., Chakrabarti, A., Colombo, A.L., Fernández, M.S., Martin-Gomez, M.T., Badali, H., Petrikkos, G., Klimko, N., Heimann, S.M., Uzun, O., Roudbary, M., de la Fuente, S., Houbraken, J., Risslegger, B., Lass-Flörl, C., Lackner, M.
Azole-resistance in Aspergillus terreus and related species: An emerging problem or a rare Phenomenon?
(2018) Frontiers in Microbiology, 9 (MAR), art. no. 516, . 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044825355&doi=10.3389%2ffmicb.2018.00516&partnerID=40&md5=e26624dd5e2aa8c380e12cef69939174

DOI: 10.3389/fmicb.2018.00516

Bartoletti, M., Tedeschi, S., Pascale, R., Raumer, L., Maraolo, A.E., Palmiero, G., Tumietto, F., Cristini, F., Ambretti, S., Giannella, M., Lewis, R.E., Viale, P.
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections
(2018) International Journal of Antimicrobial Agents, 51 (3), pp. 516-521. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043374905&doi=10.1016%2fj.ijantimicag.2018.01.010&partnerID=40&md5=ceec083eee1d1b57c167a5ebd7ea2f4e

DOI: 10.1016/j.ijantimicag.2018.01.010

Giannella, M., Trecarichi, E.M., Giacobbe, D.R., De Rosa, F.G., Bassetti, M., Bartoloni, A., Bartoletti, M., Losito, A.R., del Bono, V., Corcione, S., Tedeschi, S., Raffaelli, F., Saffioti, C., Spanu, T., Rossolini, G.M., Marchese, A., Ambretti, S., Cauda, R., Viscoli, C., Lewis, R.E., Viale, P., Tumbarello, M., on behalf of, Italian Study Group on Resistant Infections of the Societa Italiana Terapia Antinfettiva (ISGRI-SITA)
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection
(2018) International Journal of Antimicrobial Agents, 51 (2), pp. 244-248. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040603189&doi=10.1016%2fj.ijantimicag.2017.08.019&partnerID=40&md5=ffe9d035431ce742f79c412c14ca3f43

DOI: 10.1016/j.ijantimicag.2017.08.019

Shelburne, S.A., Lewis, R.E., Kontoyiannis, D.P.
Clinical Approach to Infections in the Compromised Host
(2018) Hematology: Basic Principles and Practice, pp. 1447-1461. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055770629&doi=10.1016%2fB978-0-323-35762-3.00089-5&partnerID=40&md5=7e48c9b82dd5c3687df04085dfa0f600

DOI: 10.1016/B978-0-323-35762-3.00089-5

Bartoletti, M., Lewis, R.E., Giannella, M., Tedeschi, S., Viale, P.
The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosis
(2018) Expert Review of Anti-Infective Therapy, 16 (10), pp. 771-779. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054888161&doi=10.1080%2f14787210.2018.1523716&partnerID=40&md5=5ea9a344640c212c25f507878b13e8e4

DOI: 10.1080/14787210.2018.1523716

Sassi, C., Stanzani, M., Lewis, R.E., Facchini, G., Bazzocchi, A., Cavo, M., Battista, G.
The utility of contrast-enhanced hypodense sign for the diagnosis of pulmonary invasive mould disease in patients with haematological malignancies
(2018) British Journal of Radiology, 91 (1083), art. no. 20170220, . 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043295911&doi=10.1259%2fbjr.20170220&partnerID=40&md5=69cd94cb15bdb9c04c3a4385f4e71343

DOI: 10.1259/bjr.20170220

Cesaro, S., Dalianis, T., Rinaldo, C.H., Koskenvuo, M., Pegoraro, A., Einsele, H., Cordonnier, C., Hirsch, H.H., Akova, M., Aljurf, M., Averbuch, D., Barnes, R., Blennow, O., Bochud, P.-Y., Bouza, E., Bretagne, S., Brüggemann, R., Calandra, T., Carratala, J., Cornely, O., de la Camara, R., Donnelly, P., Drgona, L., Duarte, R., Engelhard, D., Fox, C., Girmenia, C., Groll, A., Heldal, D., Helweg-Larsen, J., Herbrecht, R., Johnson, E., Klyasova, G., Lagrou, K., Lewis, R.E., Ljungman, P., Maertens, J., Mikulska, M., Nucci, M., Padoin, C., Pagano, L., Pagliuca, A., Racil, Z., Ribaud, P., Rizzi-Puechal, V., Roilides, E., Robin, C., Rovira, M., Rupp, M., Sanchez, S., Schellongowski, P., Sedlacek, P., Sinko, J., Slavin, M., Ferreira, I.S., Styczynski, J., Tissot, F., Viscoli, C., Ward, K., Witschi, A.-T., On behalf of the 6th European Conference on, Infections in Leukaemia (ECIL-6), A joint venture of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT-IDWP), the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (EORTC-IDG), the International Immunocompromised Host Society (ICHS), and the European Leukaemia Net (ELN)
ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients
(2018) Journal of Antimicrobial Chemotherapy, 73 (1), art. no. dkx324, pp. 12-21. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040622996&doi=10.1093%2fjac%2fdkx324&partnerID=40&md5=a3edc1e6bd245d75df0479a96074768b

DOI: 10.1093/jac/dkx324

Pea, F., Lewis, R.E.
Overview of antifungal dosing in invasive candidiasis
(2018) Journal of Antimicrobial Chemotherapy, 73, pp. i33-i43. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040179125&doi=10.1093%2fjac%2fdkx447&partnerID=40&md5=9720b97d374facc70a10d61655b40522

DOI: 10.1093/jac/dkx447

Mikulska, M., Averbuch, D., Tissot, F., Cordonnier, C., Akova, M., Calandra, T., Ceppi, M., Bruzzi, P., Viscoli, C., Aljurf, M., Averbuch, D., Barnes, R., Blennow, O., Bochud, P.-Y., Bouza, E., Bretagne, S., Brüggemann, R., Carratala, J., Cesaro, S., Cornely, O., Dalianis, T., De La Camara, R., Donnelly, P., Drgona, L., Duarte, R., Einsele, H., Engelhard, D., Fox, C., Girmenia, C., Groll, A., Heldal, D., Larsen, J.H., Herbrecht, R., Hirsch, H., Johnson, E., Klyasova, G., Koskuenvo, M., Lagrou, K., Lewis, R.E., Ljungman, P., Maertens, J., Maschmeyer, G., Nucci, M., Padoin, C., Pagano, L., Pagliuca, A., Racil, Z., Ribaud, P., Rinaldo, C., Puechal, V.R., Roilides, E., Robin, C., Rovira, M., Rupp, M., Sanchez, S., Schellongowski, P., Sedlacek, P., Sinko, J., Slavin, M., Ferreira, I.S., Styczynski, J., Ward, K., Witschi, A.-T., a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN), European Conference on Infections in Leukemia (ECIL)
Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines
(2018) Journal of Infection, 76 (1), pp. 20-37. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85034446796&doi=10.1016%2fj.jinf.2017.10.009&partnerID=40&md5=5564c4eb779d70a331e24ca57e4080aa

DOI: 10.1016/j.jinf.2017.10.009

Rizzello, I., Castagnetti, F., Toschi, P.G., Bertaccini, P., Primavera, L., Paolucci, M., Faccioli, L., Spinardi, L., Lewis, R.E., Cavo, M., Stanzani, M.
Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia
(2018) Mycoses, 61 (1), pp. 53-60. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85030111723&doi=10.1111%2fmyc.12697&partnerID=40&md5=8627f2555df62e774b70ca19f9841418

DOI: 10.1111/myc.12697

Gaibani, P., Lewis, R.E., Volpe, S.L., Giannella, M., Campoli, C., Landini, M.P., Viale, P., Re, M.C., Ambretti, S.
In vitro interaction of ceftazidime–avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates
(2017) International Journal of Infectious Diseases, 65, pp. 1-3. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85031109290&doi=10.1016%2fj.ijid.2017.09.017&partnerID=40&md5=758a2777d9be4a0cbd2d7518e80bd488

DOI: 10.1016/j.ijid.2017.09.017

Pierro, A., Ficarelli, S., Ayhan, N., Morini, S., Raumer, L., Bartoletti, M., Mastroianni, A., Prati, F., Schivazappa, S., Cenni, P., Vocale, C., Rossini, G., Gaibani, P., Sambri, V., Landini, M.P., Lewis, R.E., Charrel, R.N., Varani, S.
Characterization of antibody response in neuroinvasive infection caused by Toscana virus
(2017) Clinical Microbiology and Infection, 23 (11), pp. 868-873. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020035105&doi=10.1016%2fj.cmi.2017.03.017&partnerID=40&md5=0fae78b4f3927a6c3c8eefa4cc07d312

DOI: 10.1016/j.cmi.2017.03.017

Risslegger, B., Zoran, T., Lackner, M., Aigner, M., Sánchez-Reus, F., Rezusta, A., Chowdhary, A., Taj-Aldeen, S.J., Arendrup, M.C., Oliveri, S., Kontoyiannis, D.P., Alastruey-Izquierdo, A., Lagrou, K., Lo Cascio, G., Meis, J.F., Buzina, W., Farina, C., Drogari-Apiranthitou, M., Grancini, A., Tortorano, A.M., Willinger, B., Hamprecht, A., Johnson, E., Klingspor, L., Arsic-Arsenijevic, V., Cornely, O.A., Meletiadis, J., Prammer, W., Tullio, V., Vehreschild, J.-J., Trovato, L., Lewis, R.E., Segal, E., Rath, P.-M., Hamal, P., Rodriguez-Iglesias, M., Roilides, E., Arikan-Akdagli, S., Chakrabarti, A., Colombo, A.L., Fernández, M.S., Martin-Gomez, M.T., Badali, H., Petrikkos, G., Klimko, N., Heimann, S.M., Houbraken, J., Uzun, O., Edlinger, M., Fuente, S.D.L., Lass-Flörl, C.
A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study
(2017) Clinical Microbiology and Infection, 23 (10), pp. 776.e1-776.e5. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021237872&doi=10.1016%2fj.cmi.2017.04.012&partnerID=40&md5=5130267ebcc6f2a3fe8f9789a05ecdc8

DOI: 10.1016/j.cmi.2017.04.012

Giannella, M., Graziano, E., Marconi, L., Girometti, N., Bartoletti, M., Tedeschi, S., Tumietto, F., Cristini, F., Ambretti, S., Berlingeri, A., Lewis, R.E., Viale, P.
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study
(2017) European Journal of Clinical Microbiology and Infectious Diseases, 36 (10), pp. 1965-1970. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020115786&doi=10.1007%2fs10096-017-3020-x&partnerID=40&md5=299ad1cb809a6f2d557516d4300b2f8c

DOI: 10.1007/s10096-017-3020-x

Stanzani, M., Vianelli, N., Cavo, M., Maritati, A., Morotti, M., Lewis, R.E.
Retrospective cohort analysis of liposomal amphotericin b nephrotoxicity in patients with hematological malignancies
(2017) Antimicrobial Agents and Chemotherapy, 61 (9), art. no. e02651-16, . 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85028313351&doi=10.1128%2fAAC.02651-16&partnerID=40&md5=6698e3752984a0d5ae88784944ac3a6e

DOI: 10.1128/AAC.02651-16

Heo, S.T., Tatara, A.M., Jiménez-Ortigosa, C., Jiang, Y., Lewis, R.E., Tarrand, J., Tverdek, F., Albert, N.D., Verweij, P.E., Meis, J.F., Mikos, A.G., Perlin, D.S., Kontoyiannis, D.P.
Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation with Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015
(2017) Clinical Infectious Diseases, 65 (2), pp. 216-225. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85023163848&doi=10.1093%2fcid%2fcix297&partnerID=40&md5=17be7b1cd767277208340a722cfca03d

DOI: 10.1093/cid/cix297

Bartoletti, M., Martelli, G., Tedeschi, S., Morelli, M., Bertuzzo, V., Tadolini, M., Pianta, P., Cristini, F., Giannella, M., Lewis, R.E., Pinna, A.D., Viale, P.
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment
(2017) Transplant Infectious Disease, 19 (2), art. no. e12658, . 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85015165432&doi=10.1111%2ftid.12658&partnerID=40&md5=3a50ff179086db75a3cfaf94520d5d81

DOI: 10.1111/tid.12658

Sassi, C., Stanzani, M., Lewis, R.E., Vianelli, N., Tarsi, A., Poerio, A., Cavo, M., Battista, G.
Radiologic findings of Fusarium pneumonia in neutropenic patients
(2017) Mycoses, 60 (2), pp. 73-78. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84979530351&doi=10.1111%2fmyc.12538&partnerID=40&md5=a3cd02e23a8666203e27021754eebb6f

DOI: 10.1111/myc.12538

Lewis, R.E., Verweij, P.E.
Animal models for studying triazole resistance in aspergillus fumigatus
(2017) Journal of Infectious Diseases, 216, pp. S466-S473. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029695118&doi=10.1093%2finfdis%2fjix222&partnerID=40&md5=85547c33400c606938a9e35fed1c3080

DOI: 10.1093/infdis/jix222

Lewis, R.E.
Using carbapenems for carbapenem-resistant Klebsiella pneumoniae-Are we flogging a dead (work)horse antibiotic?
(2017) Virulence, 8 (1), pp. 13-14. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84991218718&doi=10.1080%2f21505594.2016.1231756&partnerID=40&md5=86f53ad3c564b9e3dee6fb85a9e33b97

DOI: 10.1080/21505594.2016.1231756

Beyda, N.D., Lewis, R.E., Kontoyiannis, D.P.
Micafungin
(2017) Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition, pp. 2681-2692. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056690254&doi=10.1201%2f9781315152110&partnerID=40&md5=39227dfd2d30fd88618b7cd65f42b521

DOI: 10.1201/9781315152110

Lewis, R.E., Beyda, N.D., Kontoyiannis, D.P.
Butenafine
(2017) Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition, pp. 2720-2724. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056686883&doi=10.1201%2f9781315152110&partnerID=40&md5=caac4c721c142c2ee11ddc1cc5fea4fa

DOI: 10.1201/9781315152110

Lewis, R.E., Beyda, N.D., Kontoyiannis, D.P.
Caspofungin
(2017) Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition, pp. 2659-2680. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056675277&doi=10.1201%2f9781315152110&partnerID=40&md5=b54a76d0cc17c4ea2479f2f5df999c52

DOI: 10.1201/9781315152110

Polverelli, N., Breccia, M., Benevolo, G., Martino, B., Tieghi, A., Latagliata, R., Sabattini, E., Riminucci, M., Godio, L., Catani, L., Nicolosi, M., Perricone, M., Sollazzo, D., Colafigli, G., Campana, A., Merli, F., Vitolo, U., Alimena, G., Martinelli, G., Lewis, R.E., Vianelli, N., Cavo, M., Palandri, F.
Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients
(2017) American Journal of Hematology, 92 (1), pp. 37-41. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85001686837&doi=10.1002%2fajh.24572&partnerID=40&md5=11594295d116209a4f2c1c1df81bc6ac

DOI: 10.1002/ajh.24572

Maschmeyer, G., Helweg-Larsen, J., Pagano, L., Robin, C., Cordonnier, C., Schellongowski, P., Akova, M., Aljurf, M., Averbuch, D., Barnes, R., Blennow, O., Bochud, P.-Y., Bouza, E., Bretagne, S., Brüggemann, R., Calandra, T., Carratalà, J., Cesaro, S., Cordonnier, C., Cornely, O., Dalianis, T., De La Camara, R., Donnelly, P., Drgona, L., Duarte, R., Einsele, H., Engelhard, D., Fox, C., Girmenia, C., Groll, A., Heldal, D., Helweg-Larsen, J., Herbrecht, R., Hirsch, H., Johnson, E., Klyasova, G., Koskuenvo, M., Lagrou, K., Lewis, R.E., Ljungman, P., Maertens, J., Maschmeyer, G., Mikulska, M., Nucci, M., Padoin, C., Dwe, A.L.L.W., Pagliuca, A., Racil, Z., Ribaud, P., Rinaldo, C., Rizzi-Puechal, V., Roilides, E., Robin, C., Rovira, M., Rupp, M., Sanchez, S., Schellongowski, P., Sedlacek, P., Sinko, J., Slavin, M., Ferreira, I.S., Styczynski, J., Tissot, F., Viscoli, C., Ward, K., Witschi, A.-T.
ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients
(2016) Journal of Antimicrobial Chemotherapy, 71 (9), pp. 2405-2413. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021787375&doi=10.1093%2fjac%2fdkw158&partnerID=40&md5=a9d89c87e249e2e5e2fe588f59a9cf5d

DOI: 10.1093/jac/dkw158

Kyvernitakis, A., Torres, H.A., Jiang, Y., Chamilos, G., Lewis, R.E., Kontoyiannis, D.P.
Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis
(2016) Clinical Microbiology and Infection, 22 (9), pp. 811.e1-811.e8. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84969528704&doi=10.1016%2fj.cmi.2016.03.029&partnerID=40&md5=75cf7113ade6391436d88ffe45d6a3fc

DOI: 10.1016/j.cmi.2016.03.029

Giannella, M., Bartoletti, M., Morelli, M., Cristini, F., Tedeschi, S., Campoli, C., Tumietto, F., Bertuzzo, V., Ercolani, G., Faenza, S., Pinna, A.D., Lewis, R.E., Viale, P.
Antifungal prophylaxis in liver transplant recipients: one size does not fit all
(2016) Transplant Infectious Disease, 18 (4), pp. 538-544. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84981210547&doi=10.1111%2ftid.12560&partnerID=40&md5=dfc7457747ea0bcef3a3779626943a8d

DOI: 10.1111/tid.12560

Bellanger, A.-P., Tatara, A.M., Shirazi, F., Gebremariam, T., Albert, N.D., Lewis, R.E., Ibrahim, A.S., Kontoyiannis, D.P.
Statin Concentrations below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae
(2016) Journal of Infectious Diseases, 214 (1), pp. 114-121. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84979234413&doi=10.1093%2finfdis%2fjiw090&partnerID=40&md5=9d6f6f7a887e93e9630acdf01036e02d

DOI: 10.1093/infdis/jiw090

Stanzani, M., Sassi, C., Battista, G., Cavo, M., Lewis, R.E.
Improved Radiographic Imaging of Invasive Fungal Disease: The Cornerstone to Antifungal Stewardship in the Hematology Units?
(2016) Current Fungal Infection Reports, 10 (2), pp. 78-86. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84963765760&doi=10.1007%2fs12281-016-0258-1&partnerID=40&md5=447c3f1ee56e4878fe38853bd2e6b3c9

DOI: 10.1007/s12281-016-0258-1

Curti, A., Ruggeri, L., Parisi, S., Bontadini, A., Dan, E., Motta, M.R., Rizzi, S., Trabanelli, S., Ocadlikova, D., Lecciso, M., Giudice, V., Fruet, F., Urbani, E., Papayannidis, C., Martinelli, G., Bandini, G., Bonifazi, F., Lewis, R.E., Cavo, M., Velardi, A., Lemoli, R.M.
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients
(2016) Clinical Cancer Research, 22 (8), pp. 1914-1921. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84966769819&doi=10.1158%2f1078-0432.CCR-15-1604&partnerID=40&md5=b6b437470958d13040d570be625643af

DOI: 10.1158/1078-0432.CCR-15-1604

Bartoletti, M., Giannella, M., Lewis, R.E., Viale, P.
Bloodstream infections in patients with liver cirrhosis
(2016) Virulence, 7 (3), pp. 309-319. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84961210027&doi=10.1080%2f21505594.2016.1141162&partnerID=40&md5=edb1446bfa93512130013ee3474f6e87

DOI: 10.1080/21505594.2016.1141162

Potenza, L., Vallerini, D., Barozzi, P., Riva, G., Gilioli, A., Forghieri, F., Candoni, A., Cesaro, S., Quadrelli, C., Maertens, J., Rossi, G., Morselli, M., Codeluppi, M., Mussini, C., Colaci, E., Messerotti, A., Paolini, A., Maccaferri, M., Fantuzzi, V., Del Giovane, C., Stefani, A., Morandi, U., Maffei, R., Marasca, R., Narni, F., Fanin, R., Comoli, P., Romani, L., Beauvais, A., Viale, P.L., Latgè, J.P., Lewis, R.E., Luppi, M.
Mucorales-specific T cells in patients with hematologic malignancies
(2016) PLoS ONE, 11 (2), art. no. e0149108, . 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84960540663&doi=10.1371%2fjournal.pone.0149108&partnerID=40&md5=2d7996f2d0fdde5fe07acaa567d14bc2

DOI: 10.1371/journal.pone.0149108

Bellanger, A.-P., Albert, N.D., Lewis, R.E., Walsh, T.J., Kontoyiannis, D.P.
Effect of preexposure to triazoles on susceptibility and virulence of Rhizopus oryzae
(2015) Antimicrobial Agents and Chemotherapy, 59 (12), pp. 7830-7832. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84954524497&doi=10.1128%2fAAC.01583-15&partnerID=40&md5=deccdb8993f8f06deb73f02254059b48

DOI: 10.1128/AAC.01583-15

Shirazi, F., Lewis, R.E., Kontoyiannis, D.P.
Micafungin induced apoptosis in candida parapsilosis independent of its susceptibility to micafungin
(2015) Microbial Cell, 2 (11), pp. 445-450. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048980713&doi=10.15698%2fmic2015.11.236&partnerID=40&md5=3cccb39e50288c9da8b020b8644461fe

DOI: 10.15698/mic2015.11.236

Viale, P., Scudeller, L., Pea, F., Tedeschi, S., Lewis, R., Bartoletti, M., Sbrojavacca, R., Cristini, F., Tumietto, F., Di Lauria, N., Fasulo, G., Giannella, M.
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis
(2015) Annals of Pharmacotherapy, 49 (9), pp. 978-985. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84940203503&doi=10.1177%2f1060028015586012&partnerID=40&md5=c9311d2ffaa1cd0b18c93f934e1dc50a

DOI: 10.1177/1060028015586012

Viale, P., Giannella, M., Bartoletti, M., Tedeschi, S., Lewis, R.
Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae
(2015) Infectious Diseases and Therapy, 4, pp. 65-83. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84977110874&doi=10.1007%2fs40121-015-0081-y&partnerID=40&md5=53f419dfa9f2a34abf82ac3047c33282

DOI: 10.1007/s40121-015-0081-y

Beyda, N.D., Liao, G., Endres, B.T., Lewis, R.E., Garey, K.W.
Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates
(2015) Antimicrobial Agents and Chemotherapy, 59 (9), pp. 5405-5412. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84940910092&doi=10.1128%2fAAC.00624-15&partnerID=40&md5=0a367d86444f60f12e2e7c989a7abb2d

DOI: 10.1128/AAC.00624-15

Viale, P., Giannella, M., Tedeschi, S., Lewis, R.
Treatment of MDR-Gram negative infections in the 21st century: a never ending threat for clinicians
(2015) Current Opinion in Pharmacology, 24, art. no. 1438, pp. 30-37. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937714393&doi=10.1016%2fj.coph.2015.07.001&partnerID=40&md5=1e43ca1d57f1f149f047a6052504b498

DOI: 10.1016/j.coph.2015.07.001

Stanzani, M., Sassi, C., Lewis, R.E., Tolomelli, G., Bazzocchi, A., Cavo, M., Vianelli, N., Battista, G.
High resolution computed tomography angiography improves the radiographic diagnosis of invasive mold disease in patients with hematological malignancies
(2015) Clinical Infectious Diseases, 60 (11), pp. 1603-1610. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930386747&doi=10.1093%2fcid%2fciv154&partnerID=40&md5=568872a128abbca7953d450e4dc58b6c

DOI: 10.1093/cid/civ154

Giannella, M., Bartoletti, M., Morelli, M.C., Tedeschi, S., Cristini, F., Tumietto, F., Pasqualini, E., Danese, I., Campoli, C., Lauria, N.D., Faenza, S., Ercolani, G., Lewis, R., Pinna, A.D., Viale, P.
Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae after liver transplantation: The importance of pre- and posttransplant colonization
(2015) American Journal of Transplantation, 15 (6), pp. 1708-1715. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929506022&doi=10.1111%2fajt.13136&partnerID=40&md5=3eac35a3990ae9f22b49951c6b7a47e6

DOI: 10.1111/ajt.13136

Sassi, C., Stanzani, M., Lewis, R.E.
Computerized tomographic pulmonary angiography discriminates invasive mould disease of the lung from lymphoma
(2015) British Journal of Haematology, 169 (4), pp. 462-462. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84928398547&doi=10.1111%2fbjh.13356&partnerID=40&md5=8eee6e05986402c395f9cdb012395025

DOI: 10.1111/bjh.13356

Lewis, R.E., Giannella, M., Viale, P.
Serum galactomannan diagnosis of breakthrough invasive fungal disease
(2015) Clinical Infectious Diseases, 60 (8), p. 1284. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84926681809&doi=10.1093%2fcid%2fciv035&partnerID=40&md5=39106749eb8241597f53e8ef45c45fa5

DOI: 10.1093/cid/civ035

Giannella, M., Ercolani, G., Cristini, F., Morelli, M., Bartoletti, M., Bertuzzo, V., Tedeschi, S., Faenza, S., Puggioli, C., Lewis, R.E., Pinna, A.D., Viale, P.
High-dose weekly liposomal amphotericin B antifungal prophylaxis in patients undergoing liver transplantation: A prospective phase II trial
(2015) Transplantation, 99 (4), pp. 848-854. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930166371&doi=10.1097%2fTP.0000000000000393&partnerID=40&md5=1abd4a01c895594b194132d8dbfbbe40

DOI: 10.1097/TP.0000000000000393

Lewis, R.E., Viale, P.
Drug interactions with voriconazole
(2015) Voriconazole: Pharmacokinetics, Role in Therapeutic Drug Monitoring and Clinical Outcomes, pp. 129-139. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84956799840&partnerID=40&md5=166ff5f14e728a763f716ba24be7c2ef


Viale, P., Lewis, R.E.
Voriconazole treatment in invasive candidiasis
(2015) Voriconazole: Pharmacokinetics, Role in Therapeutic Drug Monitoring and Clinical Outcomes, pp. 41-52. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84956759969&partnerID=40&md5=b3cbedc1d4ef410ed625d83a407a19ac


Lewis, R.E., Viale, P.
Therapeutic drug monitoring of voriconazole
(2015) Voriconazole: Pharmacokinetics, Role in Therapeutic Drug Monitoring and Clinical Outcomes, pp. 155-165. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84956719124&partnerID=40&md5=4660f3a76e4b2905c187382542b599d0


Lewis, R.E., Viale, P.
Voriconazole toxicology
(2015) Voriconazole: Pharmacokinetics, Role in Therapeutic Drug Monitoring and Clinical Outcomes, pp. 145-153. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84956709898&partnerID=40&md5=bcd08ed624af2becf2c17a93f7b658ba


Lewis, R.E., Fothergill, A.W.
Antifungal agents
(2015) Diagnosis and Treatment of Fungal Infections, pp. 79-97. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84955368848&doi=10.1007%2f9783319130903_7&partnerID=40&md5=04dba5be918c6ce4d9c9e690f4191122

DOI: 10.1007/9783319130903_7

Viale, P., Tumietto, F., Giannella, M., Bartoletti, M., Tedeschi, S., Ambretti, S., Cristini, F., Gibertoni, C., Venturi, S., Cavalli, M., De Palma, A., Puggioli, M.C., Mosci, D., Callea, E., Masina, R., Moro, M.L., Lewis, R.E.
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy
(2015) Clinical Microbiology and Infection, 21 (3), pp. 242-247. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84933531045&doi=10.1016%2fj.cmi.2014.10.020&partnerID=40&md5=a4a7b26e721eb3ea835053a7605eae23

DOI: 10.1016/j.cmi.2014.10.020

Kontoyiannis, D.P., Lewis, R.E.
Treatment principles for the management of mold infections
(2015) Cold Spring Harbor Perspectives in Medicine, 5 (4), art. no. a019737, 14 p. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84926387353&doi=10.1101%2fcshperspect.a019737&partnerID=40&md5=34a23537757f39a9c91e91e8158f8223

DOI: 10.1101/cshperspect.a019737

Giannella, M., Trecarichi, E.M., De Rosa, F.G., Del Bono, V., Bassetti, M., Lewis, R.E., Losito, A.R., Corcione, S., Saffioti, C., Bartoletti, M., Maiuro, G., Cardellino, C.S., Tedeschi, S., Cauda, R., Viscoli, C., Viale, P., Tumbarello, M.
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study
(2014) Clinical Microbiology and Infection, 20 (12), pp. 1357-1362. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84920261073&doi=10.1111%2f1469-0691.12747&partnerID=40&md5=bc242cda87fc580d1f71505a67ee7b64

DOI: 10.1111/1469-0691.12747

Lewis, R.E., Albert, N.D., Kontoyiannis, D.P.
Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis
(2014) Antimicrobial Agents and Chemotherapy, 58 (11), pp. 6767-6772. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908577004&doi=10.1128%2fAAC.03569-14&partnerID=40&md5=61f246ba650bc964ba93c673fc474594

DOI: 10.1128/AAC.03569-14

Girometti, N., Lewis, R.E., Giannella, M., Ambretti, S., Bartoletti, M., Tedeschi, S., Tumietto, F., Cristini, F., Trapani, F., Gaibani, P., Viale, P.
Klebsiella pneumoniae bloodstream infection epidemiology and impact of inappropriate empirical therapy
(2014) Medicine (United States), 93 (17), pp. 298-308. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922479671&doi=10.1097%2fMD.0000000000000111&partnerID=40&md5=35d0b6e3a972fa098fc73e5f51d75951

DOI: 10.1097/MD.0000000000000111

Kontoyiannis, D.P., Lewis, R.E.
Agents of Mucormycosis and Entomophthoramycosis
(2014) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 2, pp. 2909-2919. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84925062249&doi=10.1016%2fB978-1-4557-4801-3.00260-5&partnerID=40&md5=cd0d1251985dbdf93ab4dd3521f3587c

DOI: 10.1016/B978-1-4557-4801-3.00260-5

Di Paolo, A., Polillo, M., Tascini, C., Lewis, R., Menichetti, F., Danesi, R.
Different recommendations for daptomycin dosing over time in patients with severe infections
(2014) Clinical Infectious Diseases, 58 (12), pp. 1788-1789. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901787512&doi=10.1093%2fcid%2fciu230&partnerID=40&md5=b961bf8319de0d9e10d879db6dd17353

DOI: 10.1093/cid/ciu230

Lewis, R.E., Liao, G., Young, K., Douglas, C., Kontoyiannis, D.P.
Macrophage reporter cell assay for screening immunopharmacological activity of cell wall-active antifungals
(2014) Antimicrobial Agents and Chemotherapy, 58 (3), pp. 1738-1743. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896806813&doi=10.1128%2fAAC.02408-13&partnerID=40&md5=e252b3bd8d60c77d1af2d9c37cde5ad1

DOI: 10.1128/AAC.02408-13

Gomes, M.Z.R., Mulanovich, V.E., Jiang, Y., Lewis, R.E., Kontoyiannis, D.P.
Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011
(2014) Antimicrobial Agents and Chemotherapy, 58 (2), pp. 865-873. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84893448431&doi=10.1128%2fAAC.01525-13&partnerID=40&md5=ed4658f1bd2a3e79bee72cddd8eb1549

DOI: 10.1128/AAC.01525-13

Kontoyiannis, D.P., Lewis, R.E.
Reply to "Risk for invasive fungal infections during acute myeloid leukemia induction therapy: A true association with echinocandins?"
(2014) Antimicrobial Agents and Chemotherapy, 58 (8), pp. 4990-4991. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84905386756&doi=10.1128%2fAAC.03224-14&partnerID=40&md5=db296106857068620ef796c2241bdbeb

DOI: 10.1128/AAC.03224-14

Bartoletti, M., Giannella, M., Caraceni, P., Domenicali, M., Ambretti, S., Tedeschi, S., Verucchi, G., Badia, L., Lewis, R.E., Bernardi, M., Viale, P.
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis
(2014) Journal of Hepatology, 61 (1), pp. 51-58. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84902658014&doi=10.1016%2fj.jhep.2014.03.021&partnerID=40&md5=c7ab1f6bf99ba7e1c929fc048d67725c

DOI: 10.1016/j.jhep.2014.03.021

Gaibani, P., Lombardo, D., Lewis, R.E., Mercuri, M., Bonora, S., Landini, M.P., Ambretti, S.
In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates
(2014) Journal of Antimicrobial Chemotherapy, 69 (7), art. no. dku065, pp. 1856-1865. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84902455414&doi=10.1093%2fjac%2fdku065&partnerID=40&md5=701e7b4ce346b538879c8fdb19522dd0

DOI: 10.1093/jac/dku065

Giannella, M., Morelli, M.C., Cristini, F., Ercolani, G., Cescon, M., Bartoletti, M., Tedeschi, S., Pasqualini, E., Lewis, R.E., Pinna, A.D., Viale, P.
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation: A management challenge
(2014) Liver Transplantation, 20 (5), pp. 631-633. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84899548380&doi=10.1002%2flt.23857&partnerID=40&md5=8a2fb292e45e5e007c5feeac2fd1031b

DOI: 10.1002/lt.23857

Gomes, M.Z.R., Jiang, Y., Mulanovich, V.E., Lewis, R.E., Kontoyiannis, D.P.
Effectiveness of primary anti-Aspergillus prophylaxis during remission induction chemotherapy of acute myeloid leukemia
(2014) Antimicrobial Agents and Chemotherapy, 58 (5), pp. 2775-2780. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84898618434&doi=10.1128%2fAAC.01527-13&partnerID=40&md5=d1498a742446f2231a4532b1bbefc4fe

DOI: 10.1128/AAC.01527-13

Tascini, C., Sbrana, F., Flammini, S., Tagliaferri, E., Arena, F., Leonildi, A., Ciullo, I., Amadori, F., Di Paolo, A., Ripoli, A., Lewis, R., Rossolini, G.M., Menichetti, F., Lambelet, P., Forfori, F., Viaggi, B., Papini, F., Urbani, L., Malacarne, P.
Oral gentamicin gut decontamination for prevention of KPC-producing Klebsiella pneumoniae infections: Relevance of concomitant systemic antibiotic therapy
(2014) Antimicrobial Agents and Chemotherapy, 58 (4), pp. 1972-1976. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896940185&doi=10.1128%2fAAC.02283-13&partnerID=40&md5=e70f02960393b20b423e853014dc8f79

DOI: 10.1128/AAC.02283-13

Dimopoulou, D., Hamilos, G., Tzardi, M., Lewis, R.E., Samonis, G., Kontoyiannis, D.P.
Anidulafungin versus caspofungin in a mouse model of candidiasis caused by anidulafungin-Susceptible candida parapsilosis isolates with different degrees of caspofungin susceptibility
(2014) Antimicrobial Agents and Chemotherapy, 58 (1), pp. 229-236. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84891508949&doi=10.1128%2fAAC.01025-13&partnerID=40&md5=1395f238bdc679cea7d337d7efbad214

DOI: 10.1128/AAC.01025-13

Lewis, R.E., Georgiadou, S.P., Sampsonas, F., Chamilos, G., Kontoyiannis, D.P.
Risk factors for early mortality in haematological malignancy patients with pulmonary mucormycosis
(2014) Mycoses, 57 (1), pp. 49-55. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84890798924&doi=10.1111%2fmyc.12101&partnerID=40&md5=c0c24371082cc799ebf2920a18fc2db2

DOI: 10.1111/myc.12101

Lewis, R.E., Cahyame-Zuniga, L., Leventakos, K., Chamilos, G., Ben-Ami, R., Tamboli, P., Tarrand, J., Bodey, G.P., Luna, M., Kontoyiannis, D.P.
Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: A 20-year autopsy study
(2013) Mycoses, 56 (6), pp. 638-645. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84886306657&doi=10.1111%2fmyc.12081&partnerID=40&md5=228b2d28c86a05692f3b151f647bc4be

DOI: 10.1111/myc.12081

Viale, P., Giannella, M., Lewis, R., Trecarichi, E.M., Petrosillo, N., Tumbarello, M.
Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections
(2013) Expert Review of Anti-Infective Therapy, 11 (10), pp. 1053-1063. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84886886353&doi=10.1586%2f14787210.2013.836057&partnerID=40&md5=2c4eacc5b33ac963508b8aeb1b78db5f

DOI: 10.1586/14787210.2013.836057

Stanzani, M., Lewis, R.E., Fiacchini, M., Ricci, P., Tumietto, F., Viale, P., Ambretti, S., Baccarani, M., Cavo, M., Vianelli, N.
A Risk Prediction Score for Invasive Mold Disease in Patients with Hematological Malignancies
(2013) PLoS ONE, 8 (9), art. no. e75531, . 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84884599469&doi=10.1371%2fjournal.pone.0075531&partnerID=40&md5=733496b6e4d86f00725013306638a66c

DOI: 10.1371/journal.pone.0075531

Lewis, R.E., Kontoyiannis, D.P.
Epidemiology and treatment of mucormycosis
(2013) Future Microbiology, 8 (9), pp. 1163-1175. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84884151249&doi=10.2217%2ffmb.13.78&partnerID=40&md5=9f93c3f2d88efe840587c8c86e36718b

DOI: 10.2217/fmb.13.78

Shirazi, F., Pontikos, M.A., Walsh, T.J., Albert, N., Lewis, R.E., Kontoyiannis, D.P.
Hyperthermia sensitizes rhizopus oryzae to posaconazole and itraconazole action through apoptosis
(2013) Antimicrobial Agents and Chemotherapy, 57 (9), pp. 4360-4368. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84882335844&doi=10.1128%2fAAC.00571-13&partnerID=40&md5=268d8d4dd59f26810a02f467c87dfd44

DOI: 10.1128/AAC.00571-13

Kontoyiannis, D.P., Georgiadou, S.P., Wierda, W.G., Wright, S., Albert, N.D., Ferrajoli, A., Keating, M., Lewis, R.E.
Impaired bactericidal but not fungicidal activity of polymorphonuclear neutrophils in patients with chronic lymphocytic leukemia
(2013) Leukemia and Lymphoma, 54 (8), pp. 1730-1733. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84880315137&doi=10.3109%2f10428194.2012.750723&partnerID=40&md5=231602957295d9492cc5bb591290b048

DOI: 10.3109/10428194.2012.750723

Tascini, C., Tagliaferri, E., Giani, T., Leonildi, A., Flammini, S., Casini, B., Lewis, R., Ferranti, S., Rossolini, G.M., Menichetti, F.
Synergistic activity of colistin plus rifampin against colistin-resistant kpc-producing klebsiella pneumoniae
(2013) Antimicrobial Agents and Chemotherapy, 57 (8), pp. 3990-3993. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84880260917&doi=10.1128%2fAAC.00179-13&partnerID=40&md5=695df97de7a9ff75cde696a12bade67f

DOI: 10.1128/AAC.00179-13

Beyda, N.D., Regen, S., Lewis, R.E., Garey, K.W.
Immunomodulatory agents as adjunctive therapy for the treatment of resistant Candida species
(2013) Current Fungal Infection Reports, 7 (2), pp. 119-125. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84882850246&doi=10.1007%2fs12281-013-0132-3&partnerID=40&md5=9c8e24bd1e035782773c5234771b8aab

DOI: 10.1007/s12281-013-0132-3

Lewis, R.E., Albert, N.P., Liao, G., Wang, W., Prince, R.A., Kontoyiannis, D.P.
High-dose induction liposomal amphotericin B followed by de-escalation is effective in experimental Aspergillus terreus pneumonia
(2013) Journal of Antimicrobial Chemotherapy, 68 (5), art. no. dks521, pp. 1148-1151. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84877101087&doi=10.1093%2fjac%2fdks521&partnerID=40&md5=125b3807ac6fd872338f2bf8d7d29e0e

DOI: 10.1093/jac/dks521

Girardis, M., Bassetti, M., Lewis, R.E., Viale, P.
Aggressive versus conservative initiation of antibiotics
(2013) The Lancet Infectious Diseases, 13 (5), p. 387. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84876739992&doi=10.1016%2fS1473-3099%2813%2970064-1&partnerID=40&md5=e424f07edea7444c2f71615422ffd705

DOI: 10.1016/S1473-3099(13)70064-1

Ben-Ami, R., Albert, N.D., Lewis, R.E., Kontoyiannis, D.P.
Proangiogenic growth factors potentiate in situ angiogenesis and enhance antifungal drug activity in murine invasive aspergillosis
(2013) Journal of Infectious Diseases, 207 (7), pp. 1066-1074. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84874740459&doi=10.1093%2finfdis%2fjis940&partnerID=40&md5=b850a859e1d43f68cd7fc41cc3727fce

DOI: 10.1093/infdis/jis940

Lewis, R.E., Ben-Ami, R., Best, L., Albert, N., Walsh, T.J., Kontoyiannis, D.P.
Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis
(2013) Journal of Infectious Diseases, 207 (5), pp. 834-841. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84873697234&doi=10.1093%2finfdis%2fjis767&partnerID=40&md5=d4bf23793c6e122f2ddf9d557b26e73e

DOI: 10.1093/infdis/jis767

Petrosillo, N., Giannella, M., Lewis, R., Viale, P.
Treatment of carbapenem-resistant Klebsiella pneumoniae: The state of the art
(2013) Expert Review of Anti-Infective Therapy, 11 (2), pp. 159-177. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84873905889&doi=10.1586%2feri.12.162&partnerID=40&md5=72dac7edecc8c001d7198ba994adef93

DOI: 10.1586/eri.12.162

Paolucci, M., Stanzani, M., Melchionda, F., Tolomelli, G., Castellani, G., Landini, M.P., Varani, S., Lewis, R.E., Sambri, V.
Routine use of a real-time polymerase chain reaction method for detection of bloodstream infections in neutropaenic patients
(2013) Diagnostic Microbiology and Infectious Disease, 75 (2), pp. 130-134. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872492979&doi=10.1016%2fj.diagmicrobio.2012.10.012&partnerID=40&md5=6dcc9af927b7215e5c8c59418161a575

DOI: 10.1016/j.diagmicrobio.2012.10.012

Ben-Ami, R., Watson, C.C., Lewis, R.E., Albert, N.D., Arias, C.A., Raad, I.I., Kontoyiannis, D.P.
Drosophila melanogaster as a model to explore the effects of methicillin-resistant Staphylococcus aureus strain type on virulence and response to linezolid treatment
(2013) Microbial Pathogenesis, 55 (1), pp. 16-20. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872249064&doi=10.1016%2fj.micpath.2012.11.012&partnerID=40&md5=51ab3a48c1cd96588d3a3cd0812cd29b

DOI: 10.1016/j.micpath.2012.11.012

Georgiadou, S.P., Lewis, R.E., Best, L., Torres, H.A., Champlin, R.E., Kontoyiannis, D.P.
The impact of prior invasive mold infections in leukemia patients who undergo allo-SCT in the era of triazole-based secondary prophylaxis
(2013) Bone Marrow Transplantation, 48 (1), pp. 141-143. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872158151&doi=10.1038%2fbmt.2012.89&partnerID=40&md5=22643c99c99e274d41902b235d8863dd

DOI: 10.1038/bmt.2012.89

Lewis, R.E., Viale, P.
Update on amphotericin B pharmacology and dosing for common systemic mycoses
(2012) Current Fungal Infection Reports, 6 (4), pp. 349-357. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84886730004&doi=10.1007%2fs12281-012-0107-9&partnerID=40&md5=468bbf178e133479658f11ad604f32b2

DOI: 10.1007/s12281-012-0107-9

Chavan, N.L., Young, J.K., Drezek, R.A., Lewis, R., Bikram, M.
Interactions of liposome carriers with infectious fungal hyphae reveals the role of β-glucans
(2012) Molecular Pharmaceutics, 9 (9), pp. 2489-2496. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84865956855&doi=10.1021%2fmp300097k&partnerID=40&md5=55e95cd7bad56feaf96d984528fffa78

DOI: 10.1021/mp300097k

Beyda, N.D., Lewis, R.E., Garey, K.W.
Echinocandin resistance in Candida species: Mechanisms of reduced susceptibility and therapeutic approaches [Resistencia a equinocandinas en especies de candida: Mecanismos de susceptibilidad reducida y alternativas terapéuticas]
(2012) Annals of Pharmacotherapy, 46 (7-8), pp. 1086-1096. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84864742371&doi=10.1345%2faph.1R020&partnerID=40&md5=3d72e71077ba3e7dbb64c4cf7df48e25

DOI: 10.1345/aph.1R020

Cahuayme-Zuniga, L., Lewis, R.E., Mulanovich, V.E., Kontoyiannis, D.P.
Weekly liposomal amphotericin B as secondary prophylaxis for invasive fungal infections in patients with hematological malignancies
(2012) Medical Mycology, 50 (5), pp. 543-548. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862198790&doi=10.3109%2f13693786.2011.631152&partnerID=40&md5=57eaf35197e3c1121c5e7c0703241905

DOI: 10.3109/13693786.2011.631152

Georgiadou, S.P., Pongas, G., Fitzgerald, N.E., Lewis, R.E., Rytting, M., Marom, E.M., Kontoyiannis, D.P.
Invasive mold infections in pediatric cancer patients reflect heterogeneity in etiology, presentation, and outcome: A 10-year, single-institution, retrospective study
(2012) Journal of the Pediatric Infectious Diseases Society, 1 (2), pp. 125-135. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84949134602&doi=10.1093%2fjpids%2fpis042&partnerID=40&md5=f32dff1789680707ea223711aa10edef

DOI: 10.1093/jpids/pis042

Stanzani, M., Battista, G., Sassi, C., Lewis, R.E., Tolomelli, G., Clissa, C., Femia, R., Bazzocchi, A., Tumietto, F., Viale, P., Ambretti, S., Baccarani, M., Vianelli, N.
Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies
(2012) Clinical Infectious Diseases, 54 (5), pp. 610-616. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84856891855&doi=10.1093%2fcid%2fcir861&partnerID=40&md5=bc77488735fa7ca1e45e6fef0c1838c6

DOI: 10.1093/cid/cir861

Julius, J.M., Gaikwad, A., Lowry, A., Lewis, R.E., Lozano, R.D., Dalrymple, J.L., Coleman, R.L., Smith, J.A.
Defining the role of echinocandin catechol functional groups in the development of secondary hepatocellular carcinoma
(2012) Journal of Antimicrobial Chemotherapy, 67 (2), art. no. dkr494, pp. 422-429. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862932969&doi=10.1093%2fjac%2fdkr494&partnerID=40&md5=8a80445cf8786193801fd26b03f90607

DOI: 10.1093/jac/dkr494

Spellberg, B., Ibrahim, A., Roilides, E., Lewis, R.E., Lortholary, O., Petrikkos, G., Kontoyiannis, D.P., Walsh, T.J.
Combination therapy for mucormycosis: Why, what, and how?
(2012) Clinical Infectious Diseases, 54 (SUPPL. 1), pp. S73-S78. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855883479&doi=10.1093%2fcid%2fcir885&partnerID=40&md5=376a4fd456e242ba734151565f3f4683

DOI: 10.1093/cid/cir885

Kontoyiannis, D.P., Lewis, R.E., Lotholary, O., Spellberg, B., Petrikkos, G., Roillides, E., Ibrahim, A., Walsh, T.J.
Future directions in mucormycosis research
(2012) Clinical Infectious Diseases, 54 (SUPPL. 1), pp. S79-S85. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855869013&doi=10.1093%2fcid%2fcir886&partnerID=40&md5=663f4f272e29c83439c56dc4146396cf

DOI: 10.1093/cid/cir886

Lewis, R.E., Lortholary, O., Spellberg, B., Roilides, E., Kontoyiannis, D.P., Walsh, T.J.
How does antifungal pharmacology differ for mucormycosis versus aspergillosis?
(2012) Clinical Infectious Diseases, 54 (SUPPL. 1), pp. S67-S72. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855864796&doi=10.1093%2fcid%2fcir884&partnerID=40&md5=973083cf5094912b65c4f2961c4c5823

DOI: 10.1093/cid/cir884

Lewis, R.E., Viale, P., Kontoyiannis, D.P.
The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida
(2012) Virulence, 3 (4), pp. 368-376. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84866502135&doi=10.4161%2fviru.20746&partnerID=40&md5=1f9980ac5dffe9088749ec3562065d3c

DOI: 10.4161/viru.20746

Muhammed, M., Feldmesser, M., Shubitz, L.F., Lionakis, M.S., Sil, A., Wang, Y., Glavis-Blom, J., Lewis, R.E., Galgiani, J., Casadevall, A., Kontoyiannis, D.P., Mylonakis, E.
Mouse models for the study of fungal pneumonia: A collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due to Aspergillus-Rhizopus
(2012) Virulence, 3 (3), p. 15. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862871590&partnerID=40&md5=35a82266815780b7adcc7e21496637ab


Lewis, R.E.
Importance of pharmacokinetic considerations for selecting therapy in the treatment of invasive fungal infections
(2012) American Journal of Therapeutics, 19 (1), pp. 51-63. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855663620&doi=10.1097%2fMJT.0b013e3181ff7e10&partnerID=40&md5=58aee29ede4b93be728f9cafcce44431

DOI: 10.1097/MJT.0b013e3181ff7e10

Chitasombat, M.N., Kofteridis, D.P., Jiang, Y., Tarrand, J., Lewis, R.E., Kontoyiannis, D.P.
Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer
(2012) Journal of Infection, 64 (1), pp. 68-75. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84455202347&doi=10.1016%2fj.jinf.2011.11.002&partnerID=40&md5=48bb1f2825bf17095e41a22103de2f7c

DOI: 10.1016/j.jinf.2011.11.002

Lewis, R.E.
Cutaneous mucormycosis in tornado survivors
(2011) Current Fungal Infection Reports, 5 (4), pp. 187-189. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84905104560&doi=10.1007%2fs12281-011-0068-4&partnerID=40&md5=f6c334ff207710acd8cc46bbe32c299b

DOI: 10.1007/s12281-011-0068-4

Ben-Ami, R., Garcia-Effron, G., Lewis, R.E., Gamarra, S., Leventakos, K., Perlin, D.S., Kontoyiannis, D.P.
Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance
(2011) Journal of Infectious Diseases, 204 (4), pp. 626-635. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-79960884598&doi=10.1093%2finfdis%2fjir351&partnerID=40&md5=f97115ce7fc05becfffd607626e60895

DOI: 10.1093/infdis/jir351

Kontoyiannis, D.P., Lewis, R.E.
How I treat mucormycosis
(2011) Blood, 118 (5), pp. 1216-1224. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-80051558724&doi=10.1182%2fblood-2011-03-316430&partnerID=40&md5=cf0181214da5c10bc8a697306bfda220

DOI: 10.1182/blood-2011-03-316430

Lewis, R.E.
Pharmacokinetic-pharmacodynamic optimization of triazole antifungal therapy
(2011) Current Opinion in Infectious Diseases, 24 (SUPPL. 2), pp. S14-S29. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-79959835114&doi=10.1097%2f01.qco.0000399603.91138.e7&partnerID=40&md5=6a9594b7461ba50d9cf1efee4d7cffa3

DOI: 10.1097/01.qco.0000399603.91138.e7

Lewis, R.E., Leventakos, K., Liao, G., Kontoyiannis, D.P.
Efficacy of caspofungin in neutropenic and corticosteroid-immunosuppressed murine models of invasive pulmonary mucormycosis
(2011) Antimicrobial Agents and Chemotherapy, 55 (7), pp. 3584-3587. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-79959198616&doi=10.1128%2fAAC.01812-10&partnerID=40&md5=f7566ce6c11318e3b442bde8d017be84

DOI: 10.1128/AAC.01812-10

Lewis, R.E., Liao, G., Hou, J., Prince, R.A., Kontoyiannis, D.P.
Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus
(2011) Journal of Antimicrobial Chemotherapy, 66 (6), art. no. dkr142, pp. 1324-1331. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-79956035598&doi=10.1093%2fjac%2fdkr142&partnerID=40&md5=db63aad8bfb8e4fee863cdf6bf1ffd28

DOI: 10.1093/jac/dkr142

Gomes, M.Z.R., Lewis, R.E., Kontoyiannis, D.P.
Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species
(2011) Clinical Microbiology Reviews, 24 (2), pp. 411-445. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955062077&doi=10.1128%2fCMR.00056-10&partnerID=40&md5=d468b0bb855e72db4ea63a9f777de194

DOI: 10.1128/CMR.00056-10

Ben-Ami, R., Lewis, R.E., Kontoyiannis, D.P.
In vitro interactions among echinocandins against Aspergillus fumigatus: Lack of concordance among methods
(2011) Medical Mycology, 49 (3), pp. 285-288. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952654046&doi=10.3109%2f13693786.2010.530300&partnerID=40&md5=7ab1a18e9c1079bab8738608037c11f9

DOI: 10.3109/13693786.2010.530300

Lewis, R.E., Liao, G., Wang, W., Prince, R.A., Kontoyiannis, D.P.
Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection
(2011) Virulence, 2 (4), pp. 348-355. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046979740&doi=10.4161%2fviru.2.4.17074&partnerID=40&md5=bf7298a821d2e3c29256b09294300536

DOI: 10.4161/viru.2.4.17074

Chen, S.C.-A., Lewis, R.E., Kontoyiannis, D.P.
Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species
(2011) Virulence, 2 (4), . 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046979563&doi=10.4161%2fviru.2.4.16764&partnerID=40&md5=b791720e9f736f5ee7a4ee4a7b9fd96e

DOI: 10.4161/viru.2.4.16764

Lewis, R.E.
Current concepts in antifungal pharmacology
(2011) Mayo Clinic Proceedings, 86 (8), pp. 805-817. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-79960963679&doi=10.4065%2fmcp.2011.0247&partnerID=40&md5=a326500dd8876c17c3ea646fec139d10

DOI: 10.4065/mcp.2011.0247

Lewis, R.E., Pongas, G.N., Albert, N., Ben-Ami, R., Walsh, T.J., Kontoyiannis, D.P.
Activity of deferasirox in Mucorales: Influences of species and exogenous iron
(2011) Antimicrobial Agents and Chemotherapy, 55 (1), pp. 411-413. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-78650665671&doi=10.1128%2fAAC.00792-10&partnerID=40&md5=c51fc88638c68317d6989b7494ea246b

DOI: 10.1128/AAC.00792-10

Lewis, R.E.
Antifungal therapeutic drug monitoring
(2010) Current Fungal Infection Reports, 4 (3), pp. 158-167. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952105164&doi=10.1007%2fs12281-010-0023-9&partnerID=40&md5=e111df09050bb0f2bdb44e41a243ac9d

DOI: 10.1007/s12281-010-0023-9

Milito, M.A., Kontoyiannis, D.P., Lewis, R.E., Liu, P., Mawlawi, O.R., Truong, M.T., Marom, E.M.
Influence of host immunosuppression on CT findings in invasive pulmonary aspergillosis
(2010) Medical Mycology, 48 (6), pp. 817-823. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955903993&doi=10.3109%2f13693780903514872&partnerID=40&md5=4293e50e723aa191b07875a3bfaedfa5

DOI: 10.3109/13693780903514872

Ben-Ami, R., Lewis, R.E., Kontoyiannis, D.P.
Enemy of the (immunosuppressed) state: An update on the pathogenesis of Aspergillus fumigatus infection
(2010) British Journal of Haematology, 150 (4), pp. 406-417. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955148951&doi=10.1111%2fj.1365-2141.2010.08283.x&partnerID=40&md5=3865d684b5dcb62a1606e3a31a85ca7f

DOI: 10.1111/j.1365-2141.2010.08283.x

Campo, M., Lewis, R.E., Kontoyiannis, D.P.
Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009
(2010) Journal of Infection, 60 (5), pp. 331-337. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-77952544533&doi=10.1016%2fj.jinf.2010.01.010&partnerID=40&md5=b84d7ed2f4d161c12554f0e528337840

DOI: 10.1016/j.jinf.2010.01.010

Ben-Ami, R., Lewis, R.E., Leventakos, K., Latgé, J.-P., Kontoyiannis, D.P.
Cutaneous model of invasive aspergillosis
(2010) Antimicrobial Agents and Chemotherapy, 54 (5), pp. 1848-1854. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-77951248796&doi=10.1128%2fAAC.01504-09&partnerID=40&md5=4e7ba8e612d636548f519af605e432cc

DOI: 10.1128/AAC.01504-09

Chamilos, G., Bignell, E.M., Schrettl, M., Lewis, R.E., Leventakos, K., May, G.S., Haas, H., Kontoyiannis, D.P.
Exploring the concordance of aspergillus fumigatus pathogenicity in mice and Toll-deficient flies
(2010) Medical Mycology, 48 (3), pp. 506-510. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-77950552896&doi=10.3109%2f13693780903225813&partnerID=40&md5=0571abde7716e66589c73ea27ff838a2

DOI: 10.3109/13693780903225813

Lewis, R.E., Albert, N.D., Liao, G., Hou, J., Prince, R.A., Kontoyiannis, D.P.
Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis
(2010) Antimicrobial Agents and Chemotherapy, 54 (3), pp. 1298-1304. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-77149147084&doi=10.1128%2fAAC.01222-09&partnerID=40&md5=302c068eeb0a223e018457e7d38a3b09

DOI: 10.1128/AAC.01222-09

Leventakos, K., Lewis, R.E., Kontoyiannis, D.P.
Fungal infections in leukemia patients: How do we prevent and treat them?
(2010) Clinical Infectious Diseases, 50 (3), pp. 405-415. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-75749148763&doi=10.1086%2f649879&partnerID=40&md5=1423e6360fafac8aa88baec6b29844fa

DOI: 10.1086/649879

Ben-Ami, R., LaSala, P.R., Lewis, R.E., Kontoyiannis, D.P.
Lack of galactomannan reactivity in dematiaceous molds recovered from cancer patients with phaeohyphomycosis
(2010) Diagnostic Microbiology and Infectious Disease, 66 (2), pp. 200-203. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-73749086045&doi=10.1016%2fj.diagmicrobio.2009.09.015&partnerID=40&md5=c32af035d3550bb779978d701903a752

DOI: 10.1016/j.diagmicrobio.2009.09.015

Lewis, R.E.
Polyene antifungal agents
(2010) Aspergillosis: From Diagnosis to Prevention, pp. 281-305. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-83455189850&doi=10.1007%2f978-90-481-2408-4_17&partnerID=40&md5=5f31ec4ef40facefd9a84967e53f48d2

DOI: 10.1007/978-90-481-2408-4_17

Kontoyiannis, D.P., Lewis, R.E.
Studying Fungal Pathogenesis in Drosophila
(2010) Microbe, 5 (7), pp. 291-296. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952982353&doi=10.1128%2fmicrobe.5.291.1&partnerID=40&md5=59e9030000ec289dadf2e949c9a47306

DOI: 10.1128/microbe.5.291.1

Evans, S.E., Leventakos, K., Ben-Ami, R., You, D., Thakkar, S.G., Lewis, R.E., Kontoyiannis, D.P.
Toll-deficient Drosophila are resistant to infection by Pneumocystis spp. additional evidence of specificity to mammalian hosts
(2010) Virulence, 1 (6), pp. 523-525. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-79251522836&doi=10.4161%2fviru.1.6.13903&partnerID=40&md5=403f4ca032daa252bfd5f61a27be9c8e

DOI: 10.4161/viru.1.6.13903

Ben-Ami, R., Varga, J., Lewis, R.E., May, G.S., Nierman, W.C., Kontoyiannis, D.P.
Characterization of a 5-azacytidine-induced developmental Aspergillus fumigatus variant
(2010) Virulence, 1 (3), pp. 164-173. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955764848&doi=10.4161%2fviru.1.3.11750&partnerID=40&md5=0e31bd18ede1a7b861f08d828bfca594

DOI: 10.4161/viru.1.3.11750

Ben-Ami, R., Lamaris, G.A., Lewis, R.E., Kontoyiannis, D.P.
Interstrain variability in the virulence of Aspergillus fumigatus and Aspergillus terreus in a Toll-deficient Drosophila fly model of invasive aspergillosis
(2010) Medical Mycology, 48 (2), pp. 310-317. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-76649115615&doi=10.3109%2f13693780903148346&partnerID=40&md5=140606d8b874ff1d27132e0bd68e6e85

DOI: 10.3109/13693780903148346

Evans, S.E., Scott, B.L., Clement, C.G., Larson, D.T., Kontoyiannis, D., Lewis, R.E., Lasala, P.R., Pawlik, J., Peterson, J.W., Chopra, A.K., Klimpel, G., Bowden, G., Höök, M., Xu, Y., Tuvim, M.J., Dickey, B.F.
Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi
(2010) American Journal of Respiratory Cell and Molecular Biology, 42 (1), pp. 40-50. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-73949118392&doi=10.1165%2frcmb.2008-0260OC&partnerID=40&md5=b4a897663c656c29a610ae1e847ed54b

DOI: 10.1165/rcmb.2008-0260OC

Ben-Ami, R., Lewis, R.E., Tarrand, J., Leventakos, K., Kontoyiannis, D.P.
Antifungal activity of colistin against Mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection
(2010) Antimicrobial Agents and Chemotherapy, 54 (1), pp. 484-490. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-73849142302&doi=10.1128%2fAAC.00956-09&partnerID=40&md5=ab253fec9da1570ef14b1254362c6c98

DOI: 10.1128/AAC.00956-09

Ben-Ami, R., Lewis, R.E., Leventakos, K., Kontoyiannis, D.P.
Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites
(2009) Blood, 114 (26), pp. 5393-5399. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-73949113518&doi=10.1182%2fblood-2009-07-231209&partnerID=40&md5=790b22bf7d33f675a1f63ac69ec1d053

DOI: 10.1182/blood-2009-07-231209

Kofteridis, D.P., Lewis, R.E., Kontoyiannis, D.P.
Caspofungin-non-susceptible Candida isolates in cancer patients
(2009) Journal of Antimicrobial Chemotherapy, 65 (2), pp. 293-295. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-77950240283&doi=10.1093%2fjac%2fdkp444&partnerID=40&md5=bbf61a1e4b5b9611cf70792cc953110b

DOI: 10.1093/jac/dkp444

Leventakos, K., Ben-Ami, R., Lewis, R.E., Kontoyiannis, D.P.
Immunomodulating effects of antifungal therapy
(2009) Current Fungal Infection Reports, 3 (4), pp. 243-250. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-79951988976&doi=10.1007%2fs12281-009-0034-6&partnerID=40&md5=3d352a54390034ea5ae07d04122ea37d

DOI: 10.1007/s12281-009-0034-6

Sipsas, N.V., Lewis, R.E., Tarrand, J., Hachem, R., Rolston, K.V., Raad, I.I., Kontoyiannis, D.P.
Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): Stable incidence but changing epidemiology of a still frequently lethal infection
(2009) Cancer, 115 (20), pp. 4745-4752. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-70350107583&doi=10.1002%2fcncr.24507&partnerID=40&md5=e771481704c3f5c44a317ac4ace81caa

DOI: 10.1002/cncr.24507

Pongas, G.N., Ben-Ami, R., Lewis, R.E., Walsh, T.J., Kontoyiannis, D.P.
Culture medium composition affects the lethality of Cunninghamella bertholletiae in a fly model of mucormycosis
(2009) Antimicrobial Agents and Chemotherapy, 53 (10), p. 4569. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-70349324685&doi=10.1128%2fAAC.00994-09&partnerID=40&md5=4c0430181d08a7fc8cea917ce741c27c

DOI: 10.1128/AAC.00994-09

Roussos, P., Lewis, R.E., Kontoyiannis, D.P.
Azoles and antidepressants: A mini-review of the tolerability of co-administration
(2009) Mycoses, 52 (5), pp. 433-439. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-68749085146&doi=10.1111%2fj.1439-0507.2008.01677.x&partnerID=40&md5=866c47ba613f73325e54ef7d65ebf738

DOI: 10.1111/j.1439-0507.2008.01677.x

Lewis, R.E., Kontoyiannis, D.P.
Invasive aspergillosis in glucocorticoid-treated patients
(2009) Medical Mycology, 47 (SUPPL. 1), pp. S271-S281. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-67651109157&doi=10.1080%2f13693780802227159&partnerID=40&md5=13652c192a8910cfc14efb565bd6d2a5

DOI: 10.1080/13693780802227159

Wiederhold, N.P., Lewis, R.E.
Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi
(2009) Medical Mycology, 47 (4), pp. 422-432. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-67449108546&doi=10.1080%2f13693780802510224&partnerID=40&md5=9bee2aad6ecb18fa97471559a720b1a3

DOI: 10.1080/13693780802510224

Ben-Ami, R., Luna, M., Lewis, R.E., Walsh, T.J., Kontoyiannis, D.P.
A clinicopathological study of pulmonary mucormycosis in cancer patients: Extensive angioinvasion but limited inflammatory response
(2009) Journal of Infection, 59 (2), pp. 134-138. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-67949083437&doi=10.1016%2fj.jinf.2009.06.002&partnerID=40&md5=337bf71e0097bbd898a25044dd21ecd5

DOI: 10.1016/j.jinf.2009.06.002

Ben-Ami, R., Lewis, R.E., Kontoyiannis, D.P.
Invasive mould infections in the setting of hematopoietic cell transplantation: Current trends and new challenges
(2009) Current Opinion in Infectious Diseases, 22 (4), pp. 376-384. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-67651114113&doi=10.1097%2fQCO.0b013e32832db9f3&partnerID=40&md5=01f48cc027c998a96ef853ad875ef20e

DOI: 10.1097/QCO.0b013e32832db9f3

Tam, V.H., Ledesma, K.R., Schilling, A.N., Lim, T.-P., Yuan, Z., Ghose, R., Lewis, R.E.
In vivo dynamics of carbapenem-resistant Pseudomonas aeruginosa selection after suboptimal dosing
(2009) Diagnostic Microbiology and Infectious Disease, 64 (4), pp. 427-433. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-67650717924&doi=10.1016%2fj.diagmicrobio.2009.03.031&partnerID=40&md5=7b9d11690e95f13e6bf33f2a48c91a4a

DOI: 10.1016/j.diagmicrobio.2009.03.031

Chamilos, G., Nobile, C.J., Bruno, V.M., Lewis, R.E., Mitchell, A.P., Kontoyiannis, D.P.
Candida albicans Cas5, a regulator of cell wall integrity, is required for virulence in murine and toll mutant fly models
(2009) Journal of Infectious Diseases, 200 (1), pp. 152-157. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-67650667768&doi=10.1086%2f599363&partnerID=40&md5=d277d291a0681f4bbe44226110fe1325

DOI: 10.1086/599363

Lewis, R.E.
Overview of the changing epidemiology of candidemia
(2009) Current Medical Research and Opinion, 25 (7), pp. 1732-1740. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-67650433788&partnerID=40&md5=d1360ffff2bd548bcbb802c91f859df6


Sipsas, N.V., Lewis, R.E., Raad, I.I., Kontoyiannis, D.P.
Monotherapy with caspofungin for candidaemia in adult patients with cancer: a retrospective, single institution study
(2009) International Journal of Antimicrobial Agents, 34 (1), pp. 95-98. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-67349182880&doi=10.1016%2fj.ijantimicag.2009.01.006&partnerID=40&md5=0d668e50622a83b3fdffe3feddae2793

DOI: 10.1016/j.ijantimicag.2009.01.006

Lamaris, G.A., Ben-Ami, R., Lewis, R.E., Chamilos, G., Samonis, G., Kontoyiannis, D.P.
Increased virulence of zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis
(2009) Journal of Infectious Diseases, 199 (9), pp. 1399-1406. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-65649120359&doi=10.1086%2f597615&partnerID=40&md5=6f16bccd0865e0db46789ff72b7da758

DOI: 10.1086/597615

Ben-Ami, R., Lewis, R.E., Raacl, I.I., Kontoyiannis, D.P.
Phaeohyphomycosis in a tertiary care cancer center
(2009) Clinical Infectious Diseases, 48 (8), pp. 1033-1041. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-63649147703&doi=10.1086%2f597400&partnerID=40&md5=3d6312c366810571df1c976d2b3a19c3

DOI: 10.1086/597400

Pongas, G.N., Lewis, R.E., Samonis, G., Kontoyiannis, D.P.
Voriconazole-associated zygomycosis: A significant consequence of evolving antifungal prophylaxis and immunosuppression practices?
(2009) Clinical Microbiology and Infection, 15 (SUPPL. 5), pp. 93-97. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-70349980689&doi=10.1111%2fj.1469-0691.2009.02988.x&partnerID=40&md5=0814a0d00ecb3f7deb36aa32e577d848

DOI: 10.1111/j.1469-0691.2009.02988.x

Kontoyiannis, D.P., Lewis, R.E., Marr, K.
The Burden of Bacterial and Viral Infections in Hematopoietic Stem Cell Transplant
(2009) Biology of Blood and Marrow Transplantation, 15 (1 SUPPL.), pp. 128-133. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-64749101586&doi=10.1016%2fj.bbmt.2008.10.005&partnerID=40&md5=bc63af0b07b076ea88688b13ff0d6798

DOI: 10.1016/j.bbmt.2008.10.005

Garey, K.W., Vo, Q.P., Lewis, R.E., Saengcharoen, W., LaRocco, M.T., Tam, V.H.
Increased bacterial adherence and biomass in Pseudomonas aeruginosa bacteria exposed to clarithromycin
(2009) Diagnostic Microbiology and Infectious Disease, 63 (1), pp. 81-86. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-57349123991&doi=10.1016%2fj.diagmicrobio.2008.09.007&partnerID=40&md5=b4d672a16df8c9c6ca9caed81fcce690

DOI: 10.1016/j.diagmicrobio.2008.09.007

Lewis, R.E., Albert, N.D., Kontoyiannis, D.P.
Efficacy of single-dose liposomal amphotericin B or micafungin prophylaxis in a neutropenic murine model of invasive pulmonary aspergillosis
(2008) Antimicrobial Agents and Chemotherapy, 52 (11), pp. 4178-4180. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-55849139421&doi=10.1128%2fAAC.00715-08&partnerID=40&md5=9428f1a85d62037bf43b94190b91b186

DOI: 10.1128/AAC.00715-08

Garcia-Effron, G., Kontoyiannis, D.P., Lewis, R.E., Perlin, D.S.
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies
(2008) Antimicrobial Agents and Chemotherapy, 52 (11), pp. 4181-4183. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-55849137651&doi=10.1128%2fAAC.00802-08&partnerID=40&md5=4dab18bf55387d30cf05d4e47ce1e7a3

DOI: 10.1128/AAC.00802-08

Atkinson, B.J., Lewis, R.E., Kontoyiannis, D.P.
Candida lusitaniae fungemia in cancer patients: Risk factors for amphotericin B failure and outcome
(2008) Medical Mycology, 46 (6), pp. 541-546. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-51649122008&doi=10.1080%2f13693780801968571&partnerID=40&md5=c1b90d60b5dff7822085e46cd018be78

DOI: 10.1080/13693780801968571

Lamaris, G.A., Ben-Ami, R., Lewis, R.E., Kontoyiannis, D.P.
Does pre-exposure of Aspergillus fumigatus to voriconazole or posaconazole in vitro affect its virulence and the in vivo activity of subsequent posaconazole or voriconazole, respectively? A study in a fly model of aspergillosis
(2008) Journal of Antimicrobial Chemotherapy, 62 (3), pp. 539-542. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-49649120958&doi=10.1093%2fjac%2fdkn224&partnerID=40&md5=bad46064880f434f79a2a064e132ba42

DOI: 10.1093/jac/dkn224

Chamilos, G., Lewis, R.E., Kontoyiannis, D.P.
Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis
(2008) Clinical Infectious Diseases, 47 (4), pp. 503-509. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-48749096676&doi=10.1086%2f590004&partnerID=40&md5=389e7a2694e755f8522ab7f94bcbd143

DOI: 10.1086/590004

Lamaris, G.A., Lewis, R.E., Chamilos, G., May, G.S., Safdar, A., Walsh, T.J., Raad, I.I., Kontoyiannis, D.P.
Caspofungin-mediated β-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae
(2008) Journal of Infectious Diseases, 198 (2), pp. 186-192. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-47649090076&doi=10.1086%2f589305&partnerID=40&md5=77ca2afa71aec7269660652182d2c5a6

DOI: 10.1086/589305

Ben-Ami, R., Lewis, R.E., Kontoyiannis, D.P.
Immunopharmacology of modern antifungals
(2008) Clinical Infectious Diseases, 47 (2), pp. 226-235. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-46849095643&doi=10.1086%2f589290&partnerID=40&md5=38c996698818eb224279ecb6542498d4

DOI: 10.1086/589290

Chamilos, G., Lewis, R.E., Hu, J., Xiao, L., Zal, T., Gilliet, M., Halder, G., Kontoyiannis, D.P.
Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis
(2008) Proceedings of the National Academy of Sciences of the United States of America, 105 (27), pp. 9367-9372. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-48249108357&doi=10.1073%2fpnas.0709578105&partnerID=40&md5=6f4219748d97360593fde895bf9a41c9

DOI: 10.1073/pnas.0709578105

Lamaris, G.A., Esmaeli, B., Chamilos, G., Desai, A., Chemaly, R.F., Raad, I.I., Safdar, A., Lewis, R.E., Kontoyiannis, D.P.
Fungal endophthalmitis in a tertiary care cancer center: A review of 23 cases
(2008) European Journal of Clinical Microbiology and Infectious Diseases, 27 (5), pp. 343-347. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-43049127408&doi=10.1007%2fs10096-007-0443-9&partnerID=40&md5=8d3dbdd90b4370b7a46d8ed20133c57e

DOI: 10.1007/s10096-007-0443-9

Lewis, R.E., Albert, N.D., Kontoyiannis, D.P.
Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis
(2008) Journal of Antimicrobial Chemotherapy, 61 (5), pp. 1140-1144. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-42149128780&doi=10.1093%2fjac%2fdkn069&partnerID=40&md5=0190c8d437873ca1618314567f3c9d67

DOI: 10.1093/jac/dkn069

Chamilos, G., Lewis, R.E., Lamaris, G.A., Albert, N.D., Kontoyiannis, D.P.
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae
(2008) Antimicrobial Agents and Chemotherapy, 52 (4), pp. 1325-1329. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-42049103211&doi=10.1128%2fAAC.01393-07&partnerID=40&md5=3a5999731b60ad57e4f9eb75e4baa965

DOI: 10.1128/AAC.01393-07

Kontoyiannis, D.P., Lewis, R.E., Alexander, B.D., Lortholary, O., Dromer, F., Gupta, K.L., John, G.T., Del Busto, R., Klintmalm, G.B., Somani, J., Lyon, G.M., Pursell, K., Stosor, V., Muňoz, P., Limaye, A.P., Kalil, A.C., Pruett, T.L., Garcia-Diaz, J., Humar, A., Houston, S., House, A.A., Wray, D., Orloff, S., Dowdy, L.A., Fisher, R.A., Heitman, J., Albert, N.D., Wagener, M.M., Singh, N.
Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: Correlation with outcome in solid organ transplant recipients with cryptococcosis
(2008) Antimicrobial Agents and Chemotherapy, 52 (2), pp. 735-738. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-38649141183&doi=10.1128%2fAAC.00990-07&partnerID=40&md5=980693cd7c637c47001371941aed5cbb

DOI: 10.1128/AAC.00990-07

Chamilos, G., Lewis, R.E., Lamaris, G., Walsh, T.J., Kontoyiannis, D.P.
Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through toll-like receptor 2 induction but display relative resistance to oxidative damage
(2008) Antimicrobial Agents and Chemotherapy, 52 (2), pp. 722-724. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-38649136316&doi=10.1128%2fAAC.01136-07&partnerID=40&md5=2fe21e6245aa6d98fa245c38b29e0fd4

DOI: 10.1128/AAC.01136-07

Lewis, R.E.
What is the "therapeutic range" for voriconazole?
(2008) Clinical Infectious Diseases, 46 (2), pp. 212-214. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-39449107233&doi=10.1086%2f524670&partnerID=40&md5=c702d47aa0f1e89ef57da1848100d13a

DOI: 10.1086/524670

Lamaris, G.A., Chamilos, G., Lewis, R.E., Kontoyiannis, D.P.
Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster
(2007) Journal of Infectious Diseases, 196 (12), pp. 1860-1864. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-39149088004&doi=10.1086%2f523765&partnerID=40&md5=947c492a39d4768c06dd3bb41571dc21

DOI: 10.1086/523765

Chou, L.S., Lewis, R.E., Ippoliti, C., Champlin, R.E., Kontoyiannis, D.P.
Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients
(2007) Pharmacotherapy, 27 (12 I), pp. 1644-1650. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-36849019427&doi=10.1592%2fphco.27.12.1644&partnerID=40&md5=d89767d9b7dfb193368166252b2cc663

DOI: 10.1592/phco.27.12.1644

Mulanovich, V., Lewis, R.E., Raad, I.I., Kontoyiannis, D.P.
Random plasma concentrations of voriconazole decline over time
(2007) Journal of Infection, 55 (5), pp. e129-e130. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-35348976535&doi=10.1016%2fj.jinf.2007.07.019&partnerID=40&md5=9bab375b06a0de49de020221beda7434

DOI: 10.1016/j.jinf.2007.07.019

Lewis, R.E.
Pharmacodynamic implications for use of antifungal agents
(2007) Current Opinion in Pharmacology, 7 (5), pp. 491-497. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-35248888907&doi=10.1016%2fj.coph.2007.05.004&partnerID=40&md5=55f8c67f99859ca838886fd7dc3cf3e9

DOI: 10.1016/j.coph.2007.05.004

Orciuolo, E., Stanzani, M., Canestraro, M., Galimberti, S., Carulli, G., Lewis, R., Petrini, M., Komanduri, K.V.
Effects of Aspergillus fumigatus gliotoxin and methylprednisolone on human neutrophils: Implications for the pathogenesis of invasive aspergillosis
(2007) Journal of Leukocyte Biology, 82 (4), pp. 839-848. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-34848812855&doi=10.1189%2fjlb.0207090&partnerID=40&md5=ed952be2aa82a37509142f249fb6da9b

DOI: 10.1189/jlb.0207090

Kontoyiannis, D.P., Chamilos, G., Lewis, R.E., Giralt, S., Cortes, J., Raad, I.I., Manning, J.T., Han, X.
Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation
(2007) Cancer, 110 (6), pp. 1303-1306. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548754553&doi=10.1002%2fcncr.22909&partnerID=40&md5=1fcfa6b5fb3aa4e50f58b794bb6996e2

DOI: 10.1002/cncr.22909

Chamilos, G., Luna, M., Lewis, R.E., Chemaly, R., Raad, I.I., Kontoyiannis, D.P.
Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: A retrospective, nonrandomized autopsy study
(2007) Clinical Therapeutics, 29 (9), pp. 1980-1986. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-36749018565&doi=10.1016%2fj.clinthera.2007.09.016&partnerID=40&md5=0bcfb4745ae2167e496c22fd6bb036c1

DOI: 10.1016/j.clinthera.2007.09.016

Chamilos, G., Lewis, R.E., Albert, N., Kontoyiannis, D.P.
Paradoxical effect of echinocandins across Candida species in vitro: Evidence for Echinocandin-Specific and Candida species-related differences
(2007) Antimicrobial Agents and Chemotherapy, 51 (6), pp. 2257-2259. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-34250217778&doi=10.1128%2fAAC.00095-07&partnerID=40&md5=547ff0e9d997dd63c1d27ecab155c5fd

DOI: 10.1128/AAC.00095-07

Lewis, R.E., Liao, G., Hou, J., Chamilos, G., Prince, R.A., Kontoyiannis, D.P.
Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis
(2007) Antimicrobial Agents and Chemotherapy, 51 (4), pp. 1253-1258. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-34247146273&doi=10.1128%2fAAC.01449-06&partnerID=40&md5=4840af0f6e6fcb5dce5ad60a6b6d10bf

DOI: 10.1128/AAC.01449-06

Lewis, R.E., Chamilos, G., Prince, R.A., Kontoyiannis, D.P.
Pretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice
(2007) Antimicrobial Agents and Chemotherapy, 51 (3), pp. 1078-1081. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-33847614757&doi=10.1128%2fAAC.01268-06&partnerID=40&md5=eee9ddf02f16ceb9f94c345b2babcb6a

DOI: 10.1128/AAC.01268-06

Kontoyiannis, D.P., Chamilos, G., Hassan, S.A., Lewis, R.E., Albert, N.D., Tarrand, J.J.
Increased culture recovery of zygomycetes under physiologic temperature conditions
(2007) American Journal of Clinical Pathology, 127 (2), pp. 208-212. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-33847074258&doi=10.1309%2f7KU5XWURYM0151YN&partnerID=40&md5=4a6715eab58779ef89fe0bb0e53a3e57

DOI: 10.1309/7KU5XWURYM0151YN

Chamilos, G., Lewis, R.E., Kontoyiannis, D.P.
Multidrug-resistant endosymbiotic bacteria account for the emergence of zygomycosis: A hypothesis
(2007) Fungal Genetics and Biology, 44 (2), pp. 88-92. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-33845927849&doi=10.1016%2fj.fgb.2006.07.011&partnerID=40&md5=2e68468beb6b721db5480e442c8210c7

DOI: 10.1016/j.fgb.2006.07.011

Chamilos, G., Lionakis, M.S., Lewis, R.E., Kontoyiannis, D.P.
Role of mini-host models in the study of medically important fungi
(2007) Lancet Infectious Diseases, 7 (1), pp. 42-55. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-33845478772&doi=10.1016%2fS1473-3099%2806%2970686-7&partnerID=40&md5=bc77b4889b190fb24d04a44453131f98

DOI: 10.1016/S1473-3099(06)70686-7

Lamaris, G.A., Chamilos, G., Lewis, R.E., Safdar, A., Raad, I.I., Kontoyiannis, D.P.
Scedosporium infection in a tertiary care cancer center: A review of 25 cases from 1989-2006
(2006) Clinical Infectious Diseases, 43 (12), pp. 1580-1584. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-33845452792&doi=10.1086%2f509579&partnerID=40&md5=2e8d91ca4b08cbc9f1be264214cd3847

DOI: 10.1086/509579

Chamilos, G., Lionakis, M.S., Lewis, R.E.
Erratum: Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species (Journal of Infectious Diseases (2006) 193 (1014-1022))
(2006) Journal of Infectious Diseases, 194 (9), p. 1342. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-33750325649&doi=10.1086%2f509136&partnerID=40&md5=9f6b6a6300da8574b7927ba5731fd320

DOI: 10.1086/509136

Lewis, R.E.
Managing drug interactions in the patient with aspergillosis
(2006) Medical Mycology, 44 (SUPPL. 1), pp. 349-356. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749530696&doi=10.1080%2f13693780600835724&partnerID=40&md5=347a81dc120ecad60908d5837e1ddd88

DOI: 10.1080/13693780600835724

Kontoyiannis, D.P., Lewis, R.E.
Invasive Zygomycosis: Update on Pathogenesis, Clinical Manifestations, and Management
(2006) Infectious Disease Clinics of North America, 20 (3), pp. 581-607. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-33748519574&doi=10.1016%2fj.idc.2006.06.003&partnerID=40&md5=81b589a30bfb4097a171ee6d7154023c

DOI: 10.1016/j.idc.2006.06.003

Ashley, E.S.D., Lewis, R., Lewis, J.S., Martin, C., Andes, D.
Pharmacology of systemic antifungal agents
(2006) Clinical Infectious Diseases, 43 (SUPPL. 1), pp. S28-S39. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-33746084037&doi=10.1086%2f504492&partnerID=40&md5=6db8132dfc0508c9cb2c8ab1f00790d1

DOI: 10.1086/504492

Chamilos, G., Luna, M., Lewis, R.E., Bodey, G.P., Chemaly, R., Tarrand, J.J., Safdar, A., Raad, I.I., Kontoyiannis, D.P.
Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: An autopsy study over a 15-year period (1989-2003)
(2006) Haematologica, 91 (7), pp. 986-989. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-33745792967&partnerID=40&md5=a2b031e5862730f1c5089f3f04c41724


Lewis, R.E.
Decision making in antifungal monotherapy versus combination therapy
(2006) Pharmacotherapy, 26 (6 II), pp. 61S-67S. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-33744460745&doi=10.1592%2fphco.26.6part2.61S&partnerID=40&md5=fcd633e3be2a09480396bfa93038dd5c

DOI: 10.1592/phco.26.6part2.61S

Garey, K.W., Neuhauser, M.M., Bearden, D.T., Cannon, J.P., Lewis, R.E., Gentry, L.O., Kontoyiannis, D.P.
Evaluation of antifungals in the surgical intensive care unit: A multi-institutional study
(2006) Mycoses, 49 (3), pp. 226-231. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-33646228401&doi=10.1111%2fj.1439-0507.2006.01222.x&partnerID=40&md5=a6ea5a272026e1e14418b8559ba296f0

DOI: 10.1111/j.1439-0507.2006.01222.x

Chamilos, G., Lionakis, M.S., Lewis, R.E., Lopez-Ribot, J.L., Saville, S.P., Albert, N.D., Halder, G., Kontoyiannis, D.P.
Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species
(2006) Journal of Infectious Diseases, 193 (7), pp. 1014-1022. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-33645360264&doi=10.1086%2f500950&partnerID=40&md5=e58b96c7a644c999fccbc49ed7691226

DOI: 10.1086/500950

Lewis, R.
Judgments of value, judgments of fact: The ethical dimension of biohistorical research
(2006) Public Historian, 28 (1), pp. 93-99. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-70449945199&doi=10.1525%2ftph.2006.28.1.93&partnerID=40&md5=3ed8a10ff0b46c966051b5c52dff2eb6

DOI: 10.1525/tph.2006.28.1.93

Singh, N., Limaye, A.P., Forrest, G., Safdar, N., Muñoz, P., Pursell, K., Houston, S., Rosso, F., Montoya, J.G., Patton, P., Del Busto, R., Aguado, J.M., Fisher, R.A., Klintmalm, G.B., Miller, R., Wagener, M.M., Lewis, R.E., Kontoyiannis, D.P., Husain, S.
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: A prospective, multicenter, observational study
(2006) Transplantation, 81 (3), pp. 320-326. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-32844474763&doi=10.1097%2f01.tp.0000202421.94822.f7&partnerID=40&md5=2d6b2d76cd610b4ddf74a375acf5b556

DOI: 10.1097/01.tp.0000202421.94822.f7

Wiederhold, N.P., Tam, V.H., Chi, J., Prince, R.A., Kontoyiannis, D.P., Lewis, R.E.
Pharmacodynamic activity of amphotericin B deoxycholate is associated with peak plasma concentrations in a neutropenic murine model of invasive pulmonary aspergillosis
(2006) Antimicrobial Agents and Chemotherapy, 50 (2), pp. 469-473. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-31944450554&doi=10.1128%2fAAC.50.2.469-473.2006&partnerID=40&md5=f95ef63fc8fdc680b173fd5c58869614

DOI: 10.1128/AAC.50.2.469-473.2006

Chamilos, G., Lewis, R.E., Kontoyiannis, D.P.
Inhibition of Candida parapsilosis mitochondrial respiratory pathways enhances susceptibility to caspofungin
(2006) Antimicrobial Agents and Chemotherapy, 50 (2), pp. 744-747. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-31944442180&doi=10.1128%2fAAC.50.2.744-747.2006&partnerID=40&md5=6fdbaed1e39d099862d1ccf74be6c41f

DOI: 10.1128/AAC.50.2.744-747.2006

Dennis, C.G., Greco, W.R., Brun, Y., Youn, R., Slocum, H.K., Bernacki, R.J., Lewis, R., Wiederhold, N., Holland, S.M., Petraitiene, R., Walsh, T.J., Segal, B.H.
Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47 phox-/- mouse model of chronic granulomatous disease
(2006) Antimicrobial Agents and Chemotherapy, 50 (2), pp. 422-427. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-31944439000&doi=10.1128%2fAAC.50.2.422-427.2006&partnerID=40&md5=c10799eff69b5479464a91e89a874456

DOI: 10.1128/AAC.50.2.422-427.2006

Lewis, R.E., Wiederhold, N.P., Prince, R.A., Kontoyiannis, D.P.
In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin
(2006) Journal of Antimicrobial Chemotherapy, 57 (2), pp. 288-293. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-31544482193&doi=10.1093%2fjac%2fdki467&partnerID=40&md5=bdc5d7b728cc8be686e440ec0aff0996

DOI: 10.1093/jac/dki467

Lionakis, M.S., Chamilos, G., Lewis, R.E., Wiederhold, N.P., Raad, I.I., Samonis, G., Kontoyiannis, D.P.
Pentamidine is active in a neutropenic murine model of acute invasive pulmonary fusariosis
(2006) Antimicrobial Agents and Chemotherapy, 50 (1), pp. 294-297. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-29944447034&doi=10.1128%2fAAC.50.1.294-297.2006&partnerID=40&md5=9a919fd437d79d7e95d1f836b3121537

DOI: 10.1128/AAC.50.1.294-297.2006

Chamilos, G., Lewis, R.E., Kontoyiannis, D.P.
Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole
(2006) Antimicrobial Agents and Chemotherapy, 50 (1), pp. 96-103. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-29944441034&doi=10.1128%2fAAC.50.1.96-103.2006&partnerID=40&md5=5e26f01b962471b95990c31df31b2bbc

DOI: 10.1128/AAC.50.1.96-103.2006

Lewis, R.E., Wiederhold, N.P., Lionakis, M.S., Prince, R.A., Kontoyiannis, D.P.
Frequency and species distribution of gliotoxin-producing Aspergillus isolates recovered from patients at a tertiary-care cancer center
(2005) Journal of Clinical Microbiology, 43 (12), pp. 6120-6122. 
https://www.scopus.com/inward/record.uri?eid=2-s2.0-30744456811&doi=10.1128%2fJCM.43.12.6120-6122.2005&partnerID=40&md5=4eb944d23ca6690281a6d5e718694106

DOI: 10.1128/JCM.43.12.6120-6122.2005

### Journals

`1669`
Newton Sir I, De analysi per æquationes numero terminorum infinitas. 

`1669`
Lectiones opticæ.

etc. etc. etc.

### Patents

`2012`
Infinitesimal calculus for solutions to physics problems, [SMBC](http://www.techdirt.com/articles/20121011/09312820678/if-patents-had-been-around-time-newton.shtml) patent 001


## Occupation

`1600`
__Royal Mint__, London

- Warden
- Minted coins

`1600`
__Lucasian professor of Mathematics__, Cambridge University



<!-- ### Footer

Last updated: May 2013 -->


